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ABSTRACT 
 
Electric field mediated gene delivery modalities have preferable safety profiles with the 
ability to rapidly transfect cells in vitro and in vivo with high efficiency.  However, the current 
state of the art has relied on trial and error studies that target the average cell within a population 
present in treated tissue to derive electric pulse parameters.  This results in fixed gene 
electrotransfer (GET) parameters that are not universally optimum.  Slow progress towards the 
validation of a mechanism that explains this phenomena has also hindered its advancement in the 
clinic.  To date, GET methods utilizing feedback control as a means to optimize doses of electric 
field stimulation have not been investigated.  However, with modern electric components the 
electric characteristics of tissue exposed to electric pulses can be measured in very short time scales 
allowing for a near instantaneous assessment of the effect these pulses have on cells and tissue.  
This information is ideal for use in optimizing GET parameters to ensure the conditions necessary 
for gene delivery can be created regardless of anisotropic tissue architecture and electrode 
geometry.  Bioimpedance theory draws parallels between cell structures and circuit components 
in an attempt to use circuit theory to describe changes occurring at a cellular and tissue level.  In 
short, a reduction in tissue impedance indicates a reduction to the opposition of current flow in a 
volume conductor indicating new pathways for current.  It has been purported these new pathways 
exist in the cell membrane and indicate a degree of membrane permeability/destabilization that 
either indicates or facilitates the uptake of exogenous molecules, such as nucleic acids or plasmid 
DNA.  This study evaluated the use of relative impedance changes from 10 Hz – 10 kHz that occur 
 vii 
in tissue before and after GET to indicate relative increase in tissue and membrane permeability.  
An optimum reduction in impedance was then identified as an indicator of the degree of membrane 
permeability required to significantly enhance exogenous DNA uptake into cells.  This study 
showed the use of impedance-based feedback control to optimize GET pulse number in real time 
to target 80% or 95% reduction in tissue impedance resulted in an 12 and 14 fold increase in 
transgene expression over controls and a 6 and 7 fold increase in transgene expression over fixed 
pulse open loop protocols.
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CHAPTER 1:  BACKGROUND 
 
1.1 Gene Therapy 
The discovery of genetic components to chronic diseases and cancers has increased the 
need to manipulate gene function at the molecular level [1].  With this discovery, novel nucleic 
acid based therapeutics and methods for treating these pathologies have come to the forefront of 
medicine.  As a result, controlled delivery of nucleic acids to eukaryotic cells has become requisite 
for advancing research and development of gene-based medicine. 
Gene therapy approaches have made substantial progress and show great promise for the 
treatment of chronic diseases such as arthritis, cardiovascular disease, diabetes, autoimmune 
disease, and neurodegenerative disease [2] [3] [4] [5] [6] [7].  The central premise of these gene-
based therapies relies on either a therapeutic effect induced by properly functioning proteins 
translated from exogenously delivered genes or the rescue of proper cellular function via the 
knockdown of a gene and the function of the protein for which it codes.  The former case addresses 
pathologies associated with the absence of a properly functioning protein caused by a deleted gene 
or a mutant version which results in improperly folded protein with poor bioactivity.  Gene 
therapies resolve this disease state by providing a source for this “missing” protein.  The latter case 
addresses mutated genes that produce proteins with altered catalytic kinetics and/or binding 
affinities.  These often hyperactive proteins perpetuate a disease state while their knockdown can 
restore proper cell function [8].  Ultimately, the goal of gene therapy is to modulate expression 
and function of delivered genes to restore or enhance homeostatic activity of cells. 
2 
Identifying an absent or improperly folded, non-functioning protein, responsible for a 
diseased state in turn identifies a gene therapy target.  However, the location and function of this 
protein also determines the target cell type and delivery modality by which therapeutic genes must 
be delivered to resolve the disease.  Some diseases may be associated with a systemically 
distributed secreted protein that is absent or non-functioning, such as hemophilia or Severe 
Combined Immunodeficiency Disorder (SCID).  In cases such as these, the transfection of specific 
cell types is often not necessary as long as transfected cells can translate and express functioning 
proteins.  This is because the fate of many secreted proteins in its natural setting is often the same 
when translated in other cells not normally expressing the delivered gene.  This approach lends to 
less invasive gene delivery methods, such as electroporation or gene electrotransfer with surface 
electrodes, which indiscriminately target cells within the treatment region without regard to cell 
type.  In contrast, pathologies caused by deleted or mutant proteins with an intracellular or 
intramembrane function, not secreted by cells, require a gene delivery method that targets the cell 
type that expresses this gene.  In this case, selective transfection is required because only target 
cells possess the necessary phenotype equipped to modify and regulate the function of this protein.  
Gene therapy methods targeting specific populations of cells in deep tissue also require more 
invasive protocols.  Viral, chemical, and even physical delivery methods like GET with proper 
electrodes can target deeper cell populations but assume greater safety risks.  Delivery to deep 
tissue poses a challenge for GET methods, as catheter-based devices would need to be fabricated 
for the specific disease being targeted.  The location of protein function 
(intracellular/intramembrane or extracellular) and whether or not transfection must be cell type 
specific are the critical factors necessary for identifying the appropriate gene therapy approach [9].  
As a result, some diseases are better suited for certain gene therapy methods than others. 
3 
Identifying and targeting pathogenic proteins is not the only consideration when 
administering gene-based medicine.  The complex nature of any gene cannot be underestimated as 
each gene/protein is intimately connected, usually, with many other gene/proteins either directly 
through an equilibrium relationship or indirectly through sensitive regulatory feedback systems, 
which in turn also affect the activity of a plethora of other genes.  The forced translation of 
exogenous genes of interest can interfere with these complex regulatory feedback mechanisms if 
concentrations or activity is above physiologic levels.  This may eventually destabilize cellular 
function, then tissues, organs, and organ systems away from homeostasis toward a pathogenic 
state.  Considering this, as a safety concern, it is necessary that gene therapies target a desired level 
and duration of protein expression commensurate for resolving a disease state that also matches 
physiologic protein levels in order to not disturb homeostatic equilibria.  Rate of protein translation 
can be directly controlled by regulatory elements within exogenous nucleic acid constructs, for 
example the choice of origin of replication and enhancers in a plasmid vector can provide for high 
or low rates of protein translation.  Expression can also be induced by delivering a secondary agent 
such as doxycycline or tetracycline when the appropriate tetracycline-dependent promoter is 
incorporated into plasmids.  It is also possible to control duration of expression indirectly by 
transfecting cells that have a lifespan that matches the desired duration of targeted expression. 
Gene therapy applications for treating cancer have taken a fundamentally different 
approach where genes of interest are delivered to direct the inherent functions of immune cells to 
target and kill cancer cells.  This is also known as immunotherapy.  This method attempts to 
activate or suppress a population of immune cells including:  dendritic cells (macrophages), natural 
killer cells, cytotoxic T lymphocytes, regulatory T cells, helper T cells, or B lymphocytes.  All 
lymphoid derived cells have roles in adaptive immunity that identify and eliminate cells presenting 
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non-self antigens.  Because tumor cells present self-antigens, these immune cells are able to escape 
identification by dendritic cells and elimination by effector lymphocytes and NK cells.  Some gene 
constructs for immunotherapy encoding for cytokines and growth factors are delivered to activate 
or suppress immune cells in an attempt to eliminate anergy inducing effects of the tumor 
microenvironment and tolerance to tumor antigens.   
Cancer vaccines work in the same fashion as conventional vaccines, attempting to educate 
adaptive immune cells to identify cancer cells by exposing them to tumor associated antigens 
(TAA’s).  These vaccines contain nucleic acids that code for cancer specific TAA’s identified via 
tumor genome sequencing and require translation of encoded protein by cells to stimulate a 
therapeutically relevant concentration of antigen to induce an immune response.  DNA cancer 
vaccines can be prophylactic or therapeutic in their mode of action however like traditional 
vaccines attempt to provide long-term activation of humoral and cell mediated immune 
components to completely eradicate a tumor and prevent its reoccurrence [10] [11].  Cancer 
vaccines have been shown to induce anticancer responses against many different cancer types [12] 
[13] [14] [15].  
1.2 Skin as a Platform for Gene Therapy 
This research investigated the use of surface electrodes to facilitate electric field mediated 
gene delivery in skin.  Surface electrodes, like the multielectrode array (MEA) used in this study 
are ideal for delivering genes to superficial cells residing in the epidermis, dermis, and hypodermis 
as well as superficial tumors.  This approach is relatively noninvasive and lends to simple GET 
application with rapid protocols.  The depth of electric field penetration can be determined with 
electrode spacing; therefore, different layers of skin and populations of cells could theoretically be 
targeted for transfection by adjusting the distance between electrodes.  
5 
Target cells in the epidermis include keratinocytes, lymphocytes, and specialized antigen 
presenting dendritic cells (macrophages), referred to as Langerhans cells, which comprise up to 
8% of epidermal cells [16].  The epidermis is divided into two types, thick or thin skin, which have 
five and four layers respectively.  Thick skin occurring only on the palms of the hands and soles 
of the feet contains an additional layer called the stratum lucidum.  This layer is absent in thin skin 
which has only four distinct layers and was the target for gene therapy discussed herein.  In thin 
skin, the epidermis ranges in thickness from 75 to 150 μm and is renewed every 15 – 30 days as 
keratinocytes mature from the highly mitotic basal layer to the dead corneal layer [16].  The life 
cycle of epidermal cells can be used to control the duration of transgene expression as these cells 
live for a month at most and cannot migrate to other regions of the body.  This provides for 
temporal and spatial control of transgene expression to cells within a confined treatment region 
when using physical gene delivery methods that are not selective.  However, transfection of 
Langerhans cells can generate systemic responses due to their migratory nature especially if the 
delivered gene has an influence on the immune system. 
The structure of the epidermis contains two layers with relevant distinctions that 
significantly affect electrical characteristics and therefore cutaneous GET.  The most superficial 
layer of the epidermis, the stratum corneum, is composed of anuclear, hexagonally shaped 
corneocytes with an average diameter and height of 40 μm and 0.8 μm respectively [17].  These 
dead cells are imbedded in a protein and lipid rich matrix and together form a layer approximately 
20 μm thick with very little bound water [18].  The three living layers below the stratum corneum, 
increasing in depth include the stratum granulosum, stratum spinosum, and the stratum basale 
combine to form the remainder of the epidermis.  These layers are composed of living 
keratinocytes that range in diameter from 35 μm to 55 μm depending on their age and layer with a 
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height near 10 μm [19].  The volume fraction occupied by water in this layer is roughly 0.7 [20].  
As a result, the stratum corneum has a resistivity near 200 - 400 kΩ•m, which is approximately 
three orders of magnitude greater than the resistivity of the lower electrolyte rich layers of the 
epidermis where resistivity is near 100 - 200 Ω•m [21]. 
The integument is an excellent tissue for administering cancer vaccines.  A population of 
dendritic (Langerhans) cells reside in the epidermis as part of the mononuclear phagocyte system.  
Cancer vaccines require direct exposure of dendritic cells to TAA’s to promote antigen binding, 
processing, and presentation to T cells.  Because of their proximity to the skin exterior, surface 
electrodes have the ability to directly transfect these antigen presenting cells with a TAA encoded 
plasmid.  Transfected dendritic cells then translate, process, and present the TAA to lymphocytes 
with the potential to generate antigen specific MHC I/II restricted immune responses against 
tumors.  These same dendritic cells may also receive antigenic stimulation from TAA secreted by 
transfected keratinocytes within the treated region.  This could provide the basis for efficacy of 
cutaneous cancer vaccines. 
Similar to cancer vaccines, immunotherapies attempt to modulate humoral and cell 
mediated immune cell function to reduce autoimmunity or identify and eliminate tumor cells via 
stimulation of effector T and cells with chemokines, cytokines, antibodies, or other proteins.  
Healthy cells that having undergone neoplastic transformation to form tumors have been shown to 
modify their environment and suppress immune function [22] [23].  The microenvironment within 
tumors contains a host of suppressive cytokines overexpressed by tumors cells and a modified 
extracellular matrix highly effective at suppressing tumor immunogenicity and identification of 
tumor cells by antigen presenting cells and effector cells [24].  For example programmable death 
receptor ligand 1 (PDL1), overexpressed by tumor cells, anergizes lymphocytes and suppresses 
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the expression of anti-tumor phenotypes necessary for tumor eradication [25].  This allows tumor 
cells to evade cytotoxic T lymphocytes and unchecked tumor growth to occur.  Two approaches 
for circumventing this immune suppression include the transfection of cytokines to counteract this 
suppression by directly upregulating T cell activity and the use of checkpoint inhibitors or 
(antibodies) like anti-PDL1 that neutralize suppressive proteins released by tumors. 
1.3 Nucleic Acid Delivery Methods 
The copious charge and large size of nucleic acid constructs impede its delivery across the 
cell membrane.  For every nucleic acid within a gene construct there exists a single negative charge 
resting on a phosphate molecule, the amount of charge on deliverable nucleic acid constructs can 
accumulate quickly when considering the size of most genes.  For example, the plasmid DNA used 
in this study was composed of 6,732 base pairs, which equated to 13,464 negative charges 
associated with the phosphodiester backbone only.  However, pDNA in this case becomes 
supercoiled hiding many of those charges.  In addition to this charge, the hydrodynamic diameter 
of supercoiled DNA is typically between 200 nm to 400 nm [26] [27].  Smaller, single stranded 
genetic constructs are easier to deliver, but still pose a major challenge with respect to traversing 
the cell membrane.  To circumvent these barriers to delivery, a collection of delivery methods 
classified as either viral, chemical, physical have been developed.  Each of these methods have 
their own advantages and disadvantages.  The cell type, location of target cell, desired type of 
expression (transient or long term), need for selective transfection, cost, safety, and time are 
important factors to consideration when selecting a gene delivery method. 
1.3.1 Viral Delivery Methods 
Viral delivery exploits the innate biological machinery viruses utilize to infect host cells.  
The life cycle of a virus revolves around the delivery of its own DNA or RNA into host cells, for 
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this reason they have been a popular vehicle for delivering genes.  Viral gene delivery can produce 
higher transduction efficiency and some achieve prolonged gene expression.  However, viruses 
differ in their selectivity for transducing targeted cell types.  Some species induce transient 
expression while others permanently integrate their genes into the host genome.  There are also 
distinct differences in DNA payload capacity [28].  Popular viruses used to deliver genes with their 
respective payloads include adeno virus (AV) 36kbp of dsDNA, adeno-associated virus (AAV) 
4.7 kb of ssDNA, lentivirus (LV) 10 kb ssRNA, retrovirus (RV) 7.5 kb of ssRNA, vaccinia virus 
(VV) 190 kbp of dsDNA, and herpes simplex virus (HSV) 152 kbp dsDNA [29].  Safety issues 
with viral methods include immunogenicity and genotoxicity [29].  Stable viral gene insertion into 
the coding sequence of a host gene can create fusion proteins.  This raises the risk for insertional 
mutagenesis and subsequent carcinogenicity or nonfunctioning proteins [30].  Immunogenicity is 
also a concern.  Patients previously exposed to a virus that induced an immune response could 
experience anaphylaxis when exposed to the same viral vector used for gene delivery [31].  
Limitations in payload capacity can also restrict the size of genes available for delivery.  Lastly, 
procedures associated with viral vector preparation require lengthy protocols, higher costs, and 
stringent quality control procedures. 
1.3.2 Non-Viral Delivery Methods 
Safety, time, and economic concerns associated with viral methods have led to the advent 
of several chemical and physical techniques.  Benefits of non-viral methods include shorter 
protocols, no risk of insertional mutagenesis, non-immunogenic, biocompatibility, little to no 
toxicity, no genotoxicity, and lower costs. 
Chemical delivery methods attempt to neutralize the negative charge on the DNA backbone 
while also compressing it through encapsulation via electrostatic interactions [32] [33].  Peptides, 
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polymers, or cationic lipids are the chemical species commonly used to accomplish this [34].  
When these polyplexes form, functionalized lipids, polymers, and polypeptides can be conjugated 
with surface receptors for cell targeting and DNA release/escape [34].  However, issues with 
polydispersity and heterogeneity present in polymer-based methods reduce control over size of 
DNA polylpexes resulting in variable transfection efficiencies.  As a whole, disadvantages with in 
vivo chemical methods include cytotoxicity and low transfection efficiencies relative to viral and 
other physical methods [32]. 
Physical methods employ a physical forcing function to accomplish gene delivery that have 
preferable safety profiles without the threat of toxicity, immunogenicity, or carcinogenicity.  
Physical methods typically deliver genes on shorter time scales and require few reagents.  There 
are a collection of different physical methods for delivering pDNA including single cell laser 
cutting [35], sonoporation [36] [37], biolistic transfection (gene gun) [38], magnetic fields [39], 
and electric fields [40] [41] [42].  Physical and chemical methods produce transient transfection 
only.  This requires periodic transfection to maintain therapeutic levels of the encoded protein.  
Gene electrotransfer, the application of electric fields to tissue, represents a physical method that 
relies upon the permeabilizing effect of pulsed electric fields [43] [44] [45] [46].  When a specific 
electric field is employed to deliver genes, extracellular nucleic acids pass through the membrane 
via a mechanism that is not clearly understood has been explained through various mechanisms, 
including the formation of transient pores within the membrane that allow DNA access to the cell 
interior [47] [48].  These genetic constructs translocate to the nucleus where the gene expression 
process begins.  Permeabilizing electric fields are established by applicators containing electrodes 
in direct contact with the target tissue.  Typical electrode spacing requires the delivery of electrical 
pulses on the order of tens of volts for hundreds of milliseconds to generate field strengths within 
10 
hundreds of V/cm [49] [50].  Electric fields generated in tissues cause ions in the local extracellular 
space and within cells to collect on the inner and outer leaflets of cell membranes similar to the 
charging of a capacitor [51].  As the ions accumulate, the transmembrane potential eventually 
reaches the breakdown voltage of the insulating phospholipid bilayer resulting in current flow 
through the membrane and permeabilization [52].  Rearrangements in cell membrane structure 
following permeabilization provide new pathways for current resulting in measurable changes in 
electrical conductivity.  Changes in conductivity can then be used to indicate when changes in 
membrane permeability occur [53].  Thus, the changes in tissue conductivity and capacitance 
allows impedance spectroscopy to be used as a tool for quantifying changes in the electrical 
characteristics of cells/tissue during gene electrotransfer [53] [54] [55]. 
Current in vivo electrotransfer treatment protocols typically apply a fixed set of pulses to 
the tissue to optimize the electric field delivery parameters to obtain a desired gene delivery.  The 
pulse characteristics (field strength, pulse duration, number of pulses, etc.) are typically 
empirically derived based upon mean responses from preclinical studies.  When determining these 
optimal parameters there is currently no method available to account for differences between 
individuals with respect to chemical environment and tissue architecture.  Similarly, empirical 
approaches do not permit the ability of real-time alterations of pulse parameters in response to any 
measured parameter (such as impedance or conductivity changes in the tissue) during electrical 
treatment nor do they provide any indication of successful gene delivery.  Although GET has been 
successful and will likely have many applications in the near future, it is likely that it can be 
ultimately improved by measuring changes in electrical properties of tissue during electric field 
pulsing and then adjusting pulse parameters in real-time to achieve membrane permeability 
optimum for DNA delivery.  
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The application of gene therapy in medicine holds great promise; however, the ability to 
ensure its delivery has not been resolved.  The current state of the art employs fixed GET pulsing 
parameters that fail to account for differences in tissue architecture across organisms.  The goal of 
this research was to characterize the relationship between electric field induced changes in tissue 
impedance with gene expression.  Successful characterization of this relationship provided a 
variable for optimizing GET in real-time that describes changes in membrane permeability induced 
by pulsed electric field.  This information was then used to adjust EF pulse parameters to modulate 
cell membrane permeability towards an optimum and thus control gene delivery to cells.  Initial 
work identified a correlation between gene expression and impedance taken before, during, and 
after electric pulses were administered to tissue.  After which a deeper analysis of the frequency 
dependent nature of impedance was performed to develop an appropriate equivalent circuit model.  
This relationship will be ideal for implementation in electroporation treatment algorithms to 
accomplish targeted gene delivery across patients.  Optimizing in real-time during treatment 
ensures gene delivery occurred and allows the full potential of physical gene therapy to be realized.  
This dissertation summarizes work performed and the motivation for characterizing impedance as 
a feedback tool to be used during electroporation. 
1.4 Bioimpedance 
The analysis, characterization, and manipulation of biological tissue for the purposes of 
extracting information or application of medicine requires methods that do not disturb the natural 
processes occurring within the living system.  This demands these methods be rapid, non-invasive, 
and non-toxic.  Optical techniques such as X-rays, MRI, and fluorescence based imaging exist 
with this capability but are limited in the type of effect they can induce.  Chemical methods are 
generally too slow and toxic.  However, electric field based methods possess a unique ability to 
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characterize living systems without perturbing them as well as the ability to force changes within 
them.  Historically, the gene delivery field has used high magnitude electric fields on the order of 
hundreds of V/cm to kV/cm to induce the uptake of nucleic acids by cells.  Recently this same 
field has begun to use low magnitude electric fields (5 V/cm) that have been shown not to affect 
delivery in vivo when surface electrodes are used [56].  These label free interrogation pulses have 
also been shown to have the ability to evaluate the change in electrical characteristics of living 
tissue after electric field stimulation [56]. 
The application of this method in biological systems is referred to as bioimpedance 
spectroscopy and has been practiced for many decades to characterize biological tissues [57] [58] 
[59].  Simply stated, impedance is the sum of resistance and reactance in alternating current 
systems.  Where sources of opposition to current flow exist in not only in resistive components but 
also in structures with the ability to store charge (capacitance) and in structures that can generate 
a back electromotive force (inductance).  The utility of impedance spectroscopy comes from the 
information it can provide concerning these capacitive and inductive components.  When 
biological structures possess capacitive mechanisms, modeling them as these components can 
reveal what may be occurring physiologically in a biological system.  Bioimpedance was used in 
this study in this way to determine what effect electric fields were having on cell membranes as a 
way to guide electric field pulsing, the gene delivery forcing function. 
Electrical impedance is a complex number, represented by the letter Z with units of 
resistance or ohms (Ω) that provides information about the magnitude of the complex ratio of 
voltage to current and difference in phase between the voltage and current as a function of 
alternating current frequency (ω).  Impedance can be defined in Cartesian form (eqn. 1) or in polar 
form (eqn. 2), 
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where R is a measure of the real component of resistance (Ω), θ is the phase angle, and the 
imaginary component X is termed reactance, which is the sum of capacitive and inductive 
contributions to impedance defined as XC and XL respectively with units of ohms Ω.  Capacitive 
reactance and inductive reactance are functions of frequency and capacitance and inductance 
respectively as defined below. 
ܺ஼ ൌ ଵ௝ఠ஼ ൌ
ଵ
ఠ஼ ݁ି
ഏ
మ (3) 
ܺ௅ ൌ ݆߱ܮ ൌ ߱ܮ݁
ഏ
మ (4) 
The magnitude of impedance and phase angle shift can be calculated as the length of the position 
vector in the complex plane to a frequency dependent impedance locus and the angle this vector 
makes with the positive x-axis respectively as shown below. 
|ܼ| ൌ ඥܴଶ ൅ ሺܺ௅ െ ܺ஼ሻଶ (5) 
ߠ ൌ ݐܽ݊ିଵ ቀ௑ோቁ (6) 
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CHAPTER 2:  MOTIVATION AND SPECIFIC AIMS 
 
2.1 Motivation 
Current GET methods employ fixed, empirically derived parameters that do not 
compensate for differences in tissue architecture between organisms nor do they attempt to 
evaluate cellular response to electric pulses to ensure optimum conditions for DNA delivery are 
attained.  These open loop methods have no way of assessing the changes in tissue permeability 
that result from electric field stimulation.  Without being able to measure the degree of 
permeability induced by electric fields it is difficult to determine whether a lack of gene therapy 
efficacy was due to the gene construct or suboptimal membrane permeabilization.  Furthermore, 
open loop or fixed pulse methods lack the control needed to target a desired degree of membrane 
permeability and a corresponding targeted amount of delivery.  These limitations of the current 
state of the art provided the motivation to integrate feedback control into GET.  This was done in 
an effort to create closed loop methods that use the response of tissue during GET to adjust electric 
field parameters in real-time to achieve the targeted permeability necessary to ensure successful 
gene delivery occurs.  
This research investigated the use of an impedance spectroscope to assess the relative 
change in membrane permeability present in cells between GET pulses and to guide the number 
of pulses applied based on these changes.  Relative changes in impedance were used to decide 
whether or not electric field pulsing should cease or continue which provided for tissue specific 
electric field dosing.  Pulsing continued in each sector until tissue impedance was reduced by a 
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specified percent relative to baseline.  Pulsing in this manner provided tissue specific doses of 
electric field exposure accounting for differences in tissue architecture between treatment sectors 
and was expected to enhance gene delivery when compared to open loop, fixed pulse protocols.  
A closed loop protocol was developed to identify the stop impedance and corresponding 
permeability that correlated with maximum transgene expression.  Therefore, this research was 
designed to test the hypothesis that changes in tissue impedance could be used to identify and 
target cell/tissue permeability in a closed loop feedback GET protocol to ensure the membrane 
permeability necessary for maximum DNA delivery were created.  Ultimately, this project 
significantly improved the efficacy of GET technology to accomplish controlled gene delivery. 
2.2 Specific Aims 
This dissertation describes the characterization, validation, and utilization of impedance 
spectroscopy for the real-time optimization of in vivo gene electrotransfer.  In order to develop a 
closed loop protocol, it was first necessary to establish a correlation between impedance and gene 
expression as a function of electric field strength.  It was hypothesized that a reduction in tissue 
impedance indicated the presence of new current pathways.  These new pathways were expected 
to exist through cells, a result of membrane permeabilization induced by electric field stimulation.  
Identifying the direction of the correlation between impedance and gene delivery allowed for 
impedance changes that correspond to high gene expression to be selected.  After establishing this 
correlation, the utility of impedance as a feedback variable for optimizing gene delivery was 
evaluated.  The reporter gene expression present in treatment groups receiving closed loop GET 
that optimized pulse number to target two different stop impedances at different field strengths 
was compared to the expression in open loop, fixed pulsing GET groups of the same field strength 
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to show the impedance based closed loop methods significantly enhanced gene delivery.  Each of 
these items was addressed as a specific aim in this investigation.    
The following specific aims fully characterize this technology and optimize GET. 
2.2.1 Specific Aim i 
The purpose of specific aim i was to characterize the dependence of biological response on 
impedance changes that resulted from pulses used for pDNA delivery to skin. 
2.2.2 Specific Aim ii 
(A) Establish a pulsing algorithm that uses feedback to adjust pulsing based upon 
impedance changes.  (B) Deliver pDNA using impedance feedback based pulsing and compare 
results to open loop pulsing protocols to establish if the impedance guided pulsing scheme 
enhanced biological response.  
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CHAPTER 3:  MATERIALS AND METHODS 
 
3.1 GET/Impedance Analyzer System 
To characterize changes in tissue impedance without affecting permeability conditions, the 
interrogation signal was required to be low in magnitude relative to the scale of voltages required 
to generate GET electric fields.  Also, in order to accomplish rapid inter-GET pulse impedance 
measurements without disturbing tissue architecture during the GET protocol, it was also 
necessary to apply the GET and impedance waveforms with the same electrodes.  This required a 
set of 32 solid state relays to separate low power impedance circuitry from being damaged by the 
higher voltage GET pulses and for each to apply waveforms from their respective power supplies. 
 
Figure 1:  HV power supply, software control/laptop, SCXI chassis, impedance spectrometer 
and relay boards. 
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The impedance analyzer/GET system (Figure 1) was controlled by custom LabView 
software installed on a laptop.  GET pulses were generated by a high voltage power supply 
(Glassman High Voltage Inc., PS/EW02R300-115) and the multi frequency analog sine wave 
impedance waveforms were generated using a National Instruments (NI) USB-6361 multifunction 
input/output card.  Voltage and current signals through tissue during impedance measurement was 
measured and buffered by two instrumentation amplifiers (LT1995) before being recorded by the 
analog input channels of the USB-6361.  Sixteen electrodes in the multielectrode array were 
connected to an (NI) SCXI-1163R module housed in a NI SCXI-1000 chassis containing the 32 
solid-state relays.  A NI SCXI-1600 USB Data Acquisition and Control Module (200 kS/s) was 
used to control the isolated solid-state relay module.  Sixteen of the relays were connected to the 
ground terminal and the other sixteen were connected to the positive terminal.  The solid-state 
relays have switching time of approximately 50 ms.  The short time scale that allows a near 
instantaneous image of tissue impedance after pulsing giving this protocol its power and reliability 
to measure tissue response to electric field stimulation during GET. 
The multielectrode array (MEA) used to apply GET pulses and impedance pulses was 
constructed of 16 gold plated, cylindrical, hemispherical electrodes.  Electrodes were configured 
into a 4x4 square array and spaced 2.5 mm apart, center to center.  Spring-loaded electrodes 
allowed for good electrical contact regardless of tissue topology.  Electrodes were numbered 1 
through 16 vertically from top to bottom and left to right.  The square spaces between 4 electrodes 
were referred to as treatment sectors 1 through 9, which were labelled with the same directionality 
as electrodes.  Pulsing advanced from sectors one through 9 in numerical order. 
The motivation of this study was to show closed loop GET methods could significantly 
enhance gene delivery.  The major difference between these two methods was in the number of 
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GET pulses that were applied.  To ensure a relevant area of membranes became permeabilized 
pulses were applied in two directions: vertically and horizontally.  To ensure a relevant area of 
tissue was permeabilized in each sector each pulsed direction consisted of a pair of simultaneous 
parallel pulses from pairs of parallel electrodes.  For example in sector one a vertical pulse from 
each positive potential electrode 1 and 5 to ground potential electrode 2 and 6 was followed by a 
horizontal pulse from each positive potential electrode 1 and 2 to ground potential electrode 5 and 
6.  Open loop methods followed a fixed pulsing pattern where each animal received 8 pulses per 
sector, 2 pairs of simultaneous vertical pulses from parallel sector electrodes (4 pulses) followed 
by 2 pairs of simultaneous horizontal pulses from parallel sector electrodes (4 pulses) for a total 
of 8 pulses per sector and 72 pulses per the entire protocol.  The pulse number in closed loop 
methods varied per treatment sector as a function of impedance.  Pulsing continued in each 
treatment sector until the impedance reduction set point had been attained.  In closed loop methods, 
as pulsing advanced to a sector, first a set of four GET pulses were applied then impedance was 
measured.  A single pulse from each parallel pair of electrodes in each sector in each direction for 
a total of four pulses was applied between each impedance measurement.  This pattern of pulsing 
between impedance measurements in the closed loop pulsing regime was referred to as an 
exposure, which was equal to 4 pulses.  Once target impedance was attained, pulsing advanced to 
the next sector followed by an impedance measurement. 
3.2 Impedance Measurement 
The design of the MEA gives the electrodes the dual capability to apply both high voltage 
electric pulses necessary for inducing membrane permeability as well as the low voltage pulses 
and current measurement for quantifying tissue impedance.  A 1 V continuous sine wave excitation 
signal was generated by the impedance spectroscope containing a range of linearly spaced 
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frequencies from 10 Hz to 100 kHz over a duration of 25 ms.  This 25 ms impedance measuring 
signal was injected 50 ms after the fourth double (last) pulse in the fixed pulse DEI groups or after 
each double pulse in the DEIF groups.  After collecting voltage and current waveforms from the 
25 ms pulse, a Fast Fourier Transform (FFT) algorithm with a rectangular window implemented 
in NI Labview 2013 calculated the Fourier transform of both voltage and current waveforms 
expressed as frequency dependent complex numbers (FV (ω) and FI (ω) respectively.  The ratio of 
the magnitudes FV (ω) relative to FI (ω) was used to calculate impedance norms│Z(ω)│.  
Similarly, the phase of impedance (ϕz) was calculated as the ratio of FV (ω) (ϕV) relative to FI (ω) 
(ϕI).  Before treatment, to account for impedance associated with the MEA, applicator electrodes 
were placed on a conductive block of steel etched with a MEA footprint for securing good contact 
with electrodes.  Electrodes were then shorted with the 25 ms impedance signal and impedance 
instrumentation measurements were acquired for all nine electrode sectors.  The instrumentation 
impedance from each sector was then appropriately subtracted from the corresponding treatment 
sector spectra obtained from tissue during experiments. 
In DEIF groups, after each EF treatment sector double pulse impedance was measured.  
The mean impedance norm │Z(ω)│after each double pulse relative to baseline impedance of that 
sector was calculated.  Double pulsing of that sector then continued until the sector impedance was 
reduced by either 80% or 95% of baseline impedance.  Once the targeted reduction in impedance 
of a sector was met, the next sector received pulsing in each direction at least once followed by an 
impedance measurement to determine relative change in impedance.  Upon advancement of 
pulsing to next sector, one EF pulse was required before measuring impedance.  This required all 
sectors to receive at least on direct EF pulse. 
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3.3 Reporter Gene Plasmid 
The reporter gene expression vector used in this study was a 6,732 base pair, high 
expression circular plasmid (gWIZ-Luc, Aldevron) shown in Figure 2 with an inserted luciferase 
DNA sequence.  The regulatory elements in this plasmid allowed for high transgene expression 
via a proprietary hybrid promoter/enhancer that contained a cytomegalovirus immediate early gene 
(CMV IE) and the Intron A gene.  This expression vector also contained a high-efficiency artificial 
transcription terminator to ensure timely cleavage and release of the primary mRNA transcript 
from the transcription complex and 3’ end polyadenylation processing to occur.  The plasmid also 
included a Kanamycin resistance gene.  Relative differences in gene delivery between different 
treatment conditions were assessed via an in vivo imaging system (IVIS) images that quantified 
the number of photons emitted per second from the luciferase-catalyzed reduction of injected 
luciferin substrate.  It was expected that as more reporter gene pDNA was delivered to cells, 
luciferase copy number would increase leading to an increased number of emitted photons and 
higher radiance values upon substrate injection. 
 
Figure 2:  High expression gWIZ™ Luciferase plasmid vector map [60]. 
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CHAPTER 4:  SPECIFIC AIM I:  IMPEDANCE AND GENE EXPRESSION1 
 
4.1 Introduction 
The origin of pathologies associated with aberrant genes has been studied extensively [61] 
[62] [63] [1] [64] [65].  It is now accepted that both inherited and acquired genetic mutations are 
culpable for many chronic diseases.  Technologies with the ability to deliver correctly sequenced 
genes encoding properly functioning proteins into cells provide an excellent opportunity for the 
treatment of pathologies caused by DNA mutations that produce absent or non-functioning 
proteins.  However, delivering nucleic acids through cell membranes poses a challenge.  Nucleic 
acid constructs are orders of magnitude larger than most drugs and possess copious negative charge 
making the translocation of extracellular nucleic acids across the plasma membrane unlikely under 
normal conditions [66] [67].  To this point, a great demand exists for technology to address this 
obstacle if medicine is to harness the advantages of gene-based therapies. 
An electric field mediated in vivo gene delivery method referred to as gene electrotransfer 
(GET) has emerged as a formidable technique allowing the potential of gene-based therapies to be 
realized.  During GET, it is proposed that electric pulses temporarily permeabilize the cell 
membrane facilitating exogenous DNA uptake [68].  To improve the efficiency of GET, recent 
work has shown the status of tissue can be characterized with impedance measurements [69] [70].  
Changes in tissue and or cell impedance indicate changes in the membrane permeability present 
                                                 
1 This chapter was accepted for publication in Bioelectrochemistry and is in press.  
Copyright permission is included in Appendix A. 
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in GET attributed to electric pulses [68] [71] [72] [73] [74].  This work supports the integration of 
impedance spectroscopy into GET as a way to enhance the probability that gene delivery occurs 
by optimizing the number of electric pulses during GET treatment.  This was accomplished by 
measuring tissue impedance between pulses until an impedance level that corresponds to optimum 
cell membrane permeability and gene delivery has been attained after which pulsing ceased.  Real 
time use of tissue impedance measurements can be used to decide whether more electric pulses are 
required during a GET to maximize gene delivery.  In order to validate the potential of this method 
it is necessary to juxtapose the efficacy of GET with other methods that have contributed to gene 
delivery research. 
An array of technologies exist for enhancing the intracellular delivery of nucleic acids 
broadly classified as either viral or non-viral methods.  Viral methods employ live viruses to 
transfect host cells with a gene of interest.  This is accomplished with high efficiency but also with 
safety concerns.  Many viral vectors randomly integrate their genome into the host genome 
increasing the risk for insertional mutagenesis and subsequent malignant transformation [75].  
Other viral vectors target specific regions of the host genome for integration but with a limited 
payload capacity for exogenous nucleic acids [76] [77] [28].  Although effective, viral vectors 
raise safety concerns associated with their immunogenicity.  Natural exposure to viruses over time 
engenders immunity to their components.  These same viruses often induce immune responses 
when used to deliver genes [30] [31].  
Non-viral methods utilize physical or chemical processes to induce gene delivery.  
Chemical methods that use liposomes and cationic surfactants that encapsulate pDNA exhibit 
relatively lower transfection efficiencies and cell viability [78] [79] compared to viral methods.  
Chemical methods often involve a systemic distribution of therapeutics that may lead to unwanted 
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gene expression in untargeted cells [80].  There are a collection of different methods for delivering 
pDNA including single cell laser cutting [35], mechanical perturbation via ultrasonic treatment 
[36] [37], biolistic transfection (gene gun) [38], magnetic fields [81], and electric fields [40] [41] 
[42].  Unlike chemical methods, physical methods do not require exposure to chemicals.  Physical 
and chemical methods produce transient transfection only with periodic treatments required to 
maintain high expression levels of the encoded protein. 
GET, the application of electric fields to tissue, represents a physical method that relies 
upon the membrane permeabilizing effect of electric pulses/fields [45] [43] [44] [46].  When a 
specific electric field is employed to deliver genes, extracellular nucleic acids pass through the 
membrane via a mechanism that is not clearly understood [47] [48].  These genetic constructs 
translocate to the nucleus where the gene expression process begins.  Permeabilizing electric fields 
are established by applicators containing electrodes in direct contact with the target tissue.  Typical 
electrode spacing requires the delivery of electrical pulses on the order of tens of volts for hundreds 
of milliseconds to attain field strengths between 100 V/cm to 200 V/cm [49] [50].  These electric 
fields generated in the skin cause ions in the local extracellular space and within cells to collect on 
the inner and outer leaflets of cell membranes similar to the charging of a capacitor [51] [82].  As 
the ions accumulate, the transmembrane potential eventually reaches a breakdown voltage of the 
insulating phospholipid bilayer resulting in current flow through the membrane and 
permeabilization [52].  Rearrangements in cell membrane structure following permeabilization 
provide new pathways for current resulting in measurable changes in electrical conductivity.  
Changes in conductivity can then be used to indicate when changes in membrane permeability 
occur [53] [83] [84] [85].  Such changes in tissue conductivity and capacitance allow impedance 
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spectroscopy to be used as a tool for quantifying changes in the electrical characteristics of 
cells/tissue during gene electrotransfer [53] [54] [55] [68] [69] [70] [71] [73] [74] [86].  
Current in vivo electro transfer treatment protocols typically apply a fixed set of pulses to 
the tissue to accomplish gene delivery.  The pulse characteristics (field strength, pulse duration, 
number of pulses, etc.) are typically empirically derived based upon mean responses from 
preclinical studies.  When determining these optimal parameters, there is currently no method 
available to account for differences between individuals with respect to chemical environment and 
tissue architecture.  Similarly, empirical approaches do not permit the ability of real-time 
alterations of pulse parameters in response to any measured parameter (such as impedance or 
conductivity changes in the tissue) during electrical treatment nor do they provide any indication 
of successful gene delivery.  Although gene electrotransfer has been successful and will likely 
have many applications in the near future, it is likely that it can be ultimately improved by 
measuring changes in electrical properties during gene electrotransfer.  This paper reports on 
research efforts to identify impedance spectra characteristics of tissue that correlate with successful 
gene delivery. 
4.2 Methods 
4.2.1 Hardware 
The electric field delivery instrumentation hardware included thirty-two (32) isolated solid-
state relays within a single National Instruments (NI) SCXI-1163R module housed in a NI SCXI-
1000 chassis.  The module is controlled by an NI SCXI-1600 USB Data Acquisition and Control 
Module (200 kS/s).  Sixteen of the relays were connected to the positive terminal while the other 
sixteen relays were connected to the ground terminal of a high voltage power supply (Glassman 
High Voltage Inc., PS/EW02R300-115).  Impedance spectroscope was created from a National 
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Instruments (NI) USB-6361 multifunction input/output card that generated a multi-frequency sine 
analog voltage reference signal buffered by a unity gain high-bandwidth amplifier (Linear 
Technology LT1358) rated to drive capacitive loads.  The differential voltage across and current 
flowing through the tissue was buffered (LT1359) and measured by a pair of instrumentation 
amplifiers (LT1995) before being recorded by the analog input channels of the USB-6361.  The 
sampling rate for both the reference signal generation and voltage/current measurements was 1 
MHz.  The electric field generation and impedance measurement instrumentation were combined 
into a single composite instrument system that permitted impedance spectra to be obtained before 
and/or after electric pulses were applied using the same electrode array.  This arrangement assured 
that the electric field and the impedance measurement occurred in the same tissue region.  This 
was achieved with a series of high-voltage reed relays (Cynergy3 DAT71210) that were used to 
rapidly connect/disconnect the high voltage pulse delivery instrument and the low voltage 
impedance measurement portion of the instrument.  All devices were connected to a laptop 
computer and controlled via a custom NI Labview 2013 application. 
4.2.2 Applicator and Pulsing Sequences 
Pulsed electric fields were applied and impedance measurements were made using a direct 
contact multielectrode array (MEA) applicator, shown in Figure 3A, constructed with sixteen gold-
plated 0.54 mm diameter electrodes (S-0-c-3.7-G, Interconnect Devices).  Circular electrodes with 
rounded edges were chosen to reduce edge effects on electric field distribution associated with flat 
bottom electrodes.  The electrodes were spaced 2.5 mm apart center to center creating a square 
geometry with a side length of 8.0 mm.  This array created nine 2.5 mm by 2.5 mm square spaces 
between electrodes with each spacing referred to a sector of treated tissue.  Each electrode in the 
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MEA applicator was spring loaded, which allowed the applicator tips to conform to match the 
topology of the animal skin and ensure electrodes remain in good contact with tissue. 
Figure 3:  (A) Image of multielectrode array, (B) schematic of electrodes (1-16) with sector labels 
(S1-S9) numbering sets of 4 electrodes.  Dashed line is an indictor of the relative size of an 
intradermally injected bolus of DNA around electrodes 6, 7, 10, and 11. 
 
Treated animals received DC pulses 150 ms in duration with a 500 ms interval between 
pulses.  Figure 1B shows a schematic of electrode placement on the skin of the animal and 
numerically identifies each electrode (1-16) and sector (S1-S9).  Electric pulsing and post-pulse 
impedance measurements were conducted in each sector sequentially (S1 through S9).  For 
example, the first pulsing sequence was executed in sector one (S1) with the following pattern: 
four pulses with electrodes 1 and 5 positive potential and electrodes 2 and 6 ground.  Next, four 
pulses were applied with electrodes 1 and 2 positive and electrodes 5 and 6 ground.  Immediately 
after pulsing S1, impedance measurements were made in this sector using the same horizontal then 
vertical sequence as was used for pulsing.  Then, the system moved to Sector 2 (S2) to start the 
eight pulses in this sector followed by impedance measurements.  Each subsequent sector, S3 - S9, 
was treated in the same manner.  Impedance was measured for all sectors (horizontally and 
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vertically) immediately before the first voltage pulse in S1 to provide prepulsed values for 
comparison. 
4.2.3 Impedance Measurement 
As indicated above, the MEA applicator was used for both the application of electric fields 
for gene electrotransfer and for impedance measurements.  The impedance spectroscope generated 
a 1 V amplitude continuous sine wave excitation signal containing linearly spaced frequencies 
from 10 Hz to 100 kHz with a total duration of 25 ms. This 25 ms duration signal began 50 ms 
after the eighth (last) pulse in each sector.  Once the voltage and current waveforms were collected, 
the Fourier transform of both waveforms was calculated using the Fast Fourier Transform (FFT) 
algorithm with a rectangle window implemented in NI Labview 2013 expressed as frequency 
dependent complex numbers (FV (ω) and FI (ω) respectively).  The magnitude of the impedance 
|Z (ω)| was calculated as the ratio of magnitudes of FV (ω) relative to FI (ω) while the phase of the 
impedance (φZ) was calculated as the phase of FV (ω) (φV ) relative to FI (ω) (φI ).  Prior to any 
animal impedance spectroscopy measurements, the impedance spectrum of the MEA applicator 
electrodes were shorted and impedance measurements acquired for all sectors.  The contribution 
to the instrumentation spectra for each sector was then subtracted from all subsequent spectra 
obtained from tissue. 
4.2.4 Treatment 
Mixed sex BALB/c mice (Charles Rivers) 8-10 weeks of age were used for this study.  The 
right flank of each animal was shaved 48 hours prior to DNA delivery using standard animal 
clippers.  Immediately before treatment, animals were anesthetized in an induction chamber that 
was continuously supplied with a 2.5% isoflurane/97.5% oxygen mixture (VetEquip).  Once 
anesthetized, individual animals were removed from the induction chamber and kept anesthetized 
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under the same 2.5% isoflurane in oxygen mixture attached to a standard scavenged rodent nose 
cone.  Animals were placed on a warming pad to maintain body temperature during delivery 
procedures. 
Nine different animal groups were used to evaluate both the utility of impedance data for 
predicting the enhanced delivery of luciferase plasmid to murine skin and the impact the low 
voltage impedance measurement process had on delivery.  One treatment group was an untreated 
control group, which received neither an applied electric field treatment nor a pDNA injection.  A 
second group received pDNA only (DO).  Five treatment received pDNA followed by electric 
pulses and had impedance measurements taken before, during and after electrical treatment (DEI).  
These 5 groups varied only in the applied electric fields, which were 50 V/cm, 100 V/cm, 150 
V/cm, 200 V/cm and 250 V/cm.  The remaining two groups received pDNA and electric pulses 
(DE) and did not have impedance measurements taken.  These received electric fields of 150 V/cm 
and 200 V/cm. DNA was administered intradermally as a bolus injection by a 1ml syringe and 30-
gauge needle (BD).  Each 50 μl injection contained 100 µg of gWiz Luciferase pDNA (Aldevron) 
in phosphate buffered saline. 
4.2.5 Biological Response, Quantification, and Statistical Analysis 
Transfection was quantified from luminescence produced by the oxidation of luciferin by 
the expressed reporter gene luciferase.  Each animal was anaesthetized, as described above, and 
given a 200 µL intraperitoneal injection of D-luciferin at 15 mg/mL (Gold Biotechnology Inc.).  
Animals remained anaesthetized for 15 minutes to allow luciferin to diffuse to the treatment site 
and provide enough time for luciferin luminescence to reach a maximum.  Animals were then 
placed into a Xenogen IVIS 200 series imaging system (Caliper Life Sciences) and radiance 
(photons/s) was measured over a 10-second exposure time.  This procedure was used to collect 
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luminescence data 2, 4, 7, 10, 14 and 30 days post treatment.  Once all data was collected, the 
mean radiance and standard error of the means for each group at all time points were calculated.  
Comparison of radiance between groups to determine statistical significance was performed using 
a single-tailed Students t-test at a 95% significance level. 
4.3 Results 
4.3.1 Gene Expression 
Figure 4 shows luciferase luminescence data for a representative animal for all DO (pDNA 
only) and DEI (pDNA, electric pulses, and impedance measurements) groups 14 days post 
treatment.  Radiance of the control group that did not receive plasmid injections or exposure to 
electric fields was taken to determine background luminescence.  As expected, pDNA expression 
increased with increasing field strength for fields below 250 V/cm in which the amount of 
expression was less than that of 100 V/cm but still greater than the DNA only animals.  Measurable 
expression of luciferase in the DO group was expected, as there is typically some uptake of plasmid 
by cells at the injection site. 
 
Figure 4:  Xenogen images showing luciferase luminescence at day 14 for one representative 
animal from each group.  (A) DO group, (B) DEI-100V/cm group, (C) DEI – 150 V/cm group, 
(D) DEI-200 V/cm group, and (E) DEI-250 V/cm group. 
Luminescence / x 108 ϒ /s/cm2/sr
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Figure 5:  Mean luciferin luminescence for all groups at 2, 4, 7, 10, 14, and 30 days post 
treatment.  Error bars show the standard error of the mean for DO group (■) and DEI groups 
exposed to 100 V/cm (●), 150 V/cm (▲), 200 V/cm (♦), and 250 V/cm (▼). 
 
Figure 6 shows mean luciferase luminescence data for all DO and DEI groups 2, 4, 7, 10, 
14, and 30 days post treatment.  As expected, these levels remained constant throughout the 
duration of the experiment.  Luciferase expression levels of the DO, DE (not shown), and DEI 
groups reached a maximum on day 14 and decayed to background levels by day 30.  However, 
expression levels were near maximum at day 2 for all groups.  Biological response (luciferase 
levels) generally increased as field strength increased, suggesting a greater degree of membrane 
permeabilization and/or DNA uptake as field strength was increased.  A field of 200 V/cm 
produced the highest expression levels.  However, skin treated with a 250 V/cm field (highest 
field) produced the lowest luciferase expression levels.  These were above the levels of the DO 
group which may have indicated that a portion of cells were irreversibly permeabilized resulting 
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in cell death.  Further evidence of this was based upon macroscopically observable damage to skin.  
The radiance levels of the DEI groups where highest at day two relative to the DO group.  Animals 
exposed to 200 V/cm had the greatest increase in expression levels as indicated by the means and 
associated single-tail t-test p-value presented in Table 1.  The greatest relative expression levels 
were produced with a field strength of 200 V/cm, which exhibited a 5-fold increase in mean 
radiance relative to DO group at day two and dropped to 2.36 fold by day fourteen.  The relative 
Table 1:  Mean luciferin luminescence for all groups at 2, 4, 7, 10, 14, and 30 days post treatment.
 
 
expression levels for 100 V/cm and 150 V/cm field strengths produced relative radiance levels on 
day two that were 3.13 and 2.9 fold higher than DO group respectively.  The 200 V/cm group had 
statistically higher expression levels over the DO group for fourteen days post treatment (P = 
0.0113).  The 200 V/cm group demonstrates the highest level of DNA transfection as seen in both 
the magnitude and duration of radiance values relative to the DO group.  Impedance pulses where 
shown to have no statistically significant effect (P values greater than 0.1 at all time points in a 
two-tailed t-test) on radiance levels.  This was expected as the electric fields (0.25 V/cm) generated 
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from low voltage impedance measurements were not likely to contribute to DNA uptake.  The 
non-intrusive, label-free nature of low voltage impedance pulses are ideal for real-time electrical 
characterization without interfering with the biological process(es) being studied. 
4.3.2 Impedance Spectroscopy 
A Nyquist plot for representative impedance measurements for several representative 
sectors (S1, S4, S5, and S9 of the 16 pin array, see Figure 6) both before and after electric fields 
(EF) for a single animal in the 200 V/cm group is shown in Figure 5.  The before EF Nyquist 
curves shown in Figure 5A exhibit the same characteristic semicircular shape indicative of a 
parallel RC circuit model for cell membranes [72] and only differ by minor changes in tissue 
electrical properties and measurement noise.  The after EF Nyquist curves shown in Figure 5B 
show a dramatic decrease in the magnitude and shape of impedance relative to skin that had not 
yet been treated with electric pulses.  In addition, the after EF Nyquist curves shown in the Figure 
5C are dramatically different between each sector with sector S1 showing the smallest change in 
impedance and sectors S5 and S9 showing the largest changes in impedance behavior.  The Nyquist 
curves for sectors S1 (top-left sector, first to be receive EF) and S4 (top-middle sector) shown in 
Figure 4C also exhibit the semicircular shape predicted from the parallel RC circuit model (as seen 
in the before EF curves for all sectors) but with decreased resistance and capacitance.  However, 
the Nyquist curves for sectors S5 (central sector) and S9 (bottom-right sector, last to receive EP) 
show a marked deviation from the semicircular shape of a parallel RC circuit. 
Figure 6 shows the magnitude of impedance as a function of frequency for representative 
impedance measurements for all sectors both before and after EF for a representative animal in the 
200 V/cm group.  Similar to the Nyquist plots in Figure 4, the before EF curves all follow the same 
shape.  However, the variations in tissue impedance are more apparent such that the magnitude of 
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impedance for sector S1 is higher than that of all other sectors for all frequencies while the 
impedance of all other sectors are relatively close to each other for the before EF curves.  Figure 
6 shows the after EF magnitude of impedance for all sectors with sectors S1, S4, and S7 having 
similar shape while all other sectors follow a different shape.  A probable explanation for this is 
that effect previous electric fields generated in earlier sectors have on initiating the membrane 
permeabilization mechanism in cells in adjacent sectors.  This may explain why sector S5 has the 
lowest impedance magnitude for all frequencies as sector S5 experiences the highest number of 
previous electric field exposures. 
Figure 6:  Nyquist plot for a single representative animal in the 200 V/cm group (A) before and 
(B and C) after electric field for sectors S1, S4, S5, and S9. 
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Figure 7:  Impedance magnitude versus frequency before (circles) and after (triangles) electric 
pulses.  Sectors 1-9 from a representative animal exposed to 200 V/cm pulses in the DEI group.
 
Comparing changes in impedance for each sector is complicated by the spatial differences 
in tissue impedance as seen in the before EF Nyquist curves in Figure 5A and impedance 
magnitude curves in Figure 6.  To compare changes in impedance in different sectors before and 
after EF, the mean ratio of impedance magnitude after EF relative to before EF for DEI groups 
with field strengths of (A) 100 V/cm, (B) 150 V/cm, (C) 200 V/cm, and (D) 250 V/cm is shown 
in Figure 7.  For all field strengths shown in Figure 7, the mean ratio of impedance after EF relative 
to before EF is well below 1.0 for many frequencies.  The range of frequencies corresponding to 
mean impedance magnitude ratios less than or equal to 1.0 increased with field strength.  This 
mean ratio being below 1.0 can be easily explained by impedance being dominated by resistance 
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at low frequencies with the after EF resistance expected to be lower than that before EF due to new 
current pathways through cell membranes [36, 38].  However, the mean ratio of impedance 
magnitude after EF relative to before EF is greater than 1.0 at high frequencies in all sectors for 
both 100 V/cm and 150 V/cm and several sectors in 200 V/cm and 250 V/cm.  Since impedance 
is inversely proportional to capacitance, a mean ratio of greater than 1.0 at high frequencies may 
be due to the capacitance after EF being lower than the capacitance before EF.  The shape and 
value of the mean ratio of impedance magnitude after EF relative to before EF shown in Figure 7 
is extremely different both qualitatively and quantitatively.  First, the 100 V/cm samples (Figure 
7A) had a much smaller range of frequencies in which the mean ratio was less than 1.0 than the 
250 V/cm group (Figure 6D).  Second, the general shapes of the 100 V/cm curves (Figure 6A) for 
each sector were overtly different from those of the 250 V/cm 300 curves (Figure 6D) with the 
exception of sectors S4 and S7.  These differences may be explained by the presence of cell death 
in the 250 V/cm group as indicated by the reduced luciferase expression levels shown in Figures 
3 and 4 as well as observed tissue damage in these animals.  However, the mean ratio curves for 
sectors S4 and S7 for the 250 V/cm group were similar in shape and value to those at the lower 
field strengths. 
Figure 7B shows the mean ratio of impedance magnitude for all frequencies after EF 
relative to before EF for all animals in the 150 V/cm group while Figure 7C shows analogous data 
for the animals treated with 200 V/cm.  The 15 shape of the mean ratio of impedance magnitude 
after EF relative to before EF is similar for the 150 V/cm and 200 V/cm groups while the values 
for the 200 V/cm group are generally less than those of the 150 V/cm group.  In addition, the range 
of frequencies in which the mean ratio is less than 1.0 is greater for the 200 V/cm group relative 
to the 150 V/cm group.  These differences may be explained by increased luciferase expression 
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levels in the 200 V/cm group relative to the 150 V/cm group indicating more successful DNA 
uptake as shown in Figures 3 and 4.  Differences in the shape and the range of frequencies 
corresponding to a mean impedance magnitude ratio less than 1.0 between sectors may be due to 
unequal exposure of sectors to electric fields, a result of sector spacing, pulse timing, and/or pulse 
sequence.  A consistent pattern in these values began to emerge as field strength increased which 
implied a possible influence of electrode geometry and electrode reuse on the electric field 
conditions each sector experienced. 
 
 The mean ratio of impedance magnitude after electric field (EF) relative to before EF data 
presented in Figure 7 cannot be directly correlated with the luciferase luminescence data presented 
in Figures 3 and 4 as the biological response of each sector cannot be extracted from the overall 
 
Figure 8:  Mean ratio of impedance magnitude at all frequencies after electric field relative to 
before electric field pulses.  DEI groups with field strengths of (A) 100 V/cm, (B) 150 V/cm, 
(C) 200 V/cm, and (D) 250 V/cm, (N=12). 
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biological response due to the spatial resolution limitations of the Xenogen measurement.  
However, the mean overall ratio of impedance magnitude for all nine sectors and frequencies for 
all DEI groups (twelve animals per group) presented in Figure 8 allow for direct comparison to the 
biological response data in Figures 3 and 4.  Both sets of data are measures of overall / average 
response throughout the entire regions of tissue affected by the gene electrotransfer protocols 
tested.  Similar to the results discussed in Figure 7, Figure 8 shows both the mean ratio of 
impedance magnitude and number of frequencies in which the ratio less than 1.0 increases with 
increasing field strength.  Although the mechanism of DNA uptake during gene electrotransfer 
and its effect on the impedance spectra of tissue after experiencing an electric field is not well 
understood, the mean overall ratio of impedance magnitude presented in Figure 8 can be used as a 
template to generate a desired level of gene delivery when combined with the gene expression data 
presented in Figures 3 and 4.  For example, since the 200 V/cm group demonstrated the maximum 
level of gene expression in this study, the 200 V/cm mean overall impedance magnitude ratio 16 
curve presented in Figure 8 may be used as a target to generate optimum gene expression in a four 
by four pulsing gene electrotransfer protocol. 
 
Figure 9:  Mean overall ratio of impedance magnitude over all nine sectors at all frequencies 
after electric field relative to before electric field for all DEI groups (N=12). 
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4.4 Conclusion 
The current state-of-the-art for optimizing in vivo gene electrotransfer through membrane 
permeabilization in different tissues has historically employed a trial and error approach.  The goal 
of this study was to determine whether changes in tissue impedance correlate with biological 
responses and thus indicate successful membrane permeabilization and subsequent gene transfer.  
Experimental results showed a strong relationship between the change in impedance magnitude 
with both field strength and biological response indicating tissue impedance is an excellent 
indicator of membrane permeabilization and subsequent transfection.  The effect of low voltage 
impedance measurements before and after the application of an electric field were also evaluated 
to identify any significant contribution to membrane permeabilization.  Considering a 200 V/cm 
field strength was required to produce peak expression, it was not expected a 0.25 V/cm impedance 
interrogation field would significantly increase or improve DNA uptake.  Experimental results 
showed this to be true as there was no statistically significant difference in the biological response 
between DE and DEI groups of the same field strength.  Results also revealed differences in the 
mean ratio of after electric field relative to before electric field impedance magnitudes with respect 
to frequency between sectors.  This may be due to an unequal stimulation of sectors by electric 
fields from adjacent sectors and the timing in which this occurs.  The distribution of impedance 
magnitude after EF relative to before EF versus frequency revealed interesting differences between 
impedance changes in different sectors underscoring the significance of pulse timing and how this 
relates to membrane permeabilization kinetics.  A deeper examination of pore kinetics may provide 
insight into the pulse timing and sequence necessary for producing controlled DNA uptake in all 
sectors. 
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This research correlated identified tissue response impedance to membrane 
permeabilization via gene expression.  Future work will identify changes in dynamic electrical 
parameters to be used in optimizing gene electrotransfer algorithms in an attempt to target and 
maintain the distribution of the ratio of impedance magnitudes after EF relative to before EF versus 
frequency within a desired range similar to the 200 V/cm group shown in Figure 6C.  Parameters 
such as field strength, pulse number, frequency, and duration will be considered.  This may obviate 
protracted trial and error methods and allow for the desired level of gene delivery obtained per 
application.  Future efforts will also attempt to identify the impedance change that correlates with 
irreversible permeabilization and subsequent cell death. 
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CHAPTER 5: SPECIFIC AIM II:  IMPEDANCE CONTROLLED GENE 
ELECTROTRANSFER2 
 
5.1 Introduction 
The basis for integrating impedance measurements into GET stems from the need to 
measure and control the response of cells to EF pulses so that targeted delivery can be achieved 
consistently and maximally.  In theory, as additional pathways for current increase in a conducting 
volume, resistance to current flow through this volume decreases.  When considering a volume of 
tissue treated with EF pulses, if impedance is reduced after exposure to EFs and no significant 
change is assumed to have occurred with respect to the conductivity of the fluids comprising the 
matrix or extracellular compartments, new conductive pathways must be present in plasma 
membranes through cells to account for the reduction in impedance.  Furthermore, the dry surface 
electrodes in non-galvanic contact with tissue used in this study prevented electrochemical 
reactions at the electrodes and subsequent generation of ions that would have affected conductivity 
of extracellular fluid. 
It has been hypothesized that pulsed electric fields induce rearrangement of cell membrane 
phospholipids after dielectric breakdown creating porous discontinuities in the membrane that 
function as new current pathways through cells.  These pathways account for the reduced 
impedance seen in tissue after exposure to EF pulses.  This is necessary because tissue-to-tissue 
differences in chemical microenvironment and tissue architecture confer an anisotropic quality to 
                                                 
2 Portions of this chapter will be submitted for publication in Bioelectrochemistry. 
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tissue causing it to respond uniquely to EF pulses.  As a result, a unique number of pulses is 
required to generate target impedance and corresponding permeability in each treated region of 
tissue.  Fixed pulse number protocols do not account for differences in tissue architecture and thus 
create a nonhomogeneous profile of permeability across treatment regions.  Additionally, open 
loop fixed pulse protocols do not provide an optimum number of pulses nor do they measure tissues 
response to pulsed electric fields.  Impedance measurements present an ideal method for 
addressing the shortcomings of open loop methods due to its label free, rapid, low voltage nature, 
which have previously been shown not to affect delivery [56].  Ultimately, this may enhance 
electric field mediated gene delivery and provide for more controlled methods by utilizing closed 
loop feedback control to drive EF pulsing instead of empirically derived open loop protocols.  It 
is also possible that this method may be universally applied to all tissues significantly contributing 
to more consistent and controlled gene delivery in any electrode accessible tissue.  It was expected 
that reductions in membrane permeability could indicate when the membrane permeability 
necessary for pDNA uptake are present.  It is still unknown whether pDNA uptake occurs directly 
via electrodiffusion through transient pores created when membranes become hyperpolarized 
during EF exposure or whether EF pulses stimulate or upregulate a biological response similar to 
endocytosis that mediates transfection as recently purported [87].  Regardless, increases in 
membrane permeability would occur during both proposed phenomena during which additional 
conductive pathways would arise. 
5.2 Methods 
5.2.1 Hardware 
Instrumentation hardware (Figure 1) for generating electric fields was comprised of thirty-
two (32) isolated solid state relays contained within a National Instruments (NI) SCXI-1163R 
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module housed in a NI SCXI-1000 chassis.  A NI SCXI-1600 USB Data Acquisition and Control 
Module (200 kS/s) was used to control the isolated solid-state relay module.  Half of the relays 
were connected to the positive terminal while the other half sixteen relays were grounded to the 
high voltage power supply (Glassman High Voltage Inc., PS/EW02R300-115).  Waveforms for 
analyzing impedance were generated from a National Instruments (NI) USB-6361 multifunction 
input/output card that generated a multi-frequency sine analog voltage reference signal buffered 
by a unity gain high-bandwidth amplifier (Linear Technology LT1358) rated to drive capacitive 
loads.  The differential voltage across and current flowing through the tissue was buffered 
(LT1359) and measured by a pair of instrumentation amplifiers (LT1995) before being recorded 
by the analog input channels of the USB-6361.  The reference signal generation and 
voltage/current measurements were sampled at a frequency of 1 MHz.  Tethering the high voltage 
field generator and the impedance analyzer into a single composite device allowed for both EF 
pulses and impedance measurement execution with the same multielectrode array.  This was 
critical as it minimized error in impedance measurement associated with movement of or a break 
in electrode contact with skin.  The relays used to disconnect and connect the high voltage pulse 
delivery system and the low voltage impedance spectroscope allowed for switching times as fast 
as 50 ms after each high voltage pulse.  A series of high-voltage reed relays (Cynergy3 DAT71210) 
were used to accomplish switching.  A custom NI Labview 2013 application was installed and 
used on a laptop to control all devices. 
5.2.2 Applicator and Pulsing Sequence 
Each GET pulse, impedance pulse, and impedance measurement was performed with a 
multielectrode array (MEA) applicator (Figure 10A and B) in direct static contact with the 
treatment region for the duration of the GET protocol.  The electrode array was constructed with 
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sixteen gold-plated, flat bottom electrodes 0.54 mm in diameter (100039-025-958, Interconnect 
Devices).  The 4x4 square array had an 8.0 mm side length and 2.5 mm center-to-center spacing 
between electrodes.  Electrodes were 8.75 mm long and contained depressible spring loaded tips 
to ensure good contact with tissue regardless of topology.  With depressible to allow tips to 
maintain firm contact with tissue surface.  The square geometry and equal spacing between 
electrodes created nine 2.5 mm by 2.5 mm square spaces referred to as sectors.  Figure 9B shows 
a treatment region schematic consisting of the MEA superimposed over an intradermal pDNA 
injection (dashed circle), numeric labeling used to identify individual electrodes (1-16), and 
treatment sectors (S1-S9).  Two pulsing regimes were used to evaluate the utility of tissue 
impedance changes to optimize gene electrotransfer efficiency: a fixed pulse number regime and 
an impedance guided dynamic pulsing regime. 
Figure 10:  Image of multielectrode array(left) and (center), schematic of electrodes (1-16) with 
sector labels (S1-S9) (right). 
 
The first pulsing regime used a fixed number of 8 pulses per treatment sector that 
progressed sequentially from S1 to S9.  These treatment groups received pDNA injections, electric 
pulses, and impedance measurements (DEI groups) before EF pulsing began and after pulsing in 
each sector.  DEI treatments began with sequential impedance measurements, as described above, 
in all sectors to establish baseline skin impedance.  Following initial impedance measurements, 
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EF pulsing began in sector 1 with the following example pattern:  two 150 ms DC pulses from 
each positive potential electrode 1 and 5 to negative potential electrode 2 and 6 for a total of 4 
vertical pulses followed by two 150 ms DC pulses from each positive electrode 1 and 2 to negative 
potential electrode 5 and 6 for a total of 4 horizontal pulses.  Impedance measurements were made 
using the same pattern after vertical EF pulsing and after horizontal EF pulsing finished for a total 
of 8 1 V AC pulses.  After the last horizontal impedance in S1, EF pulsing began in S2 followed 
by the same impedance pulsing pattern as above.  This pattern continued from S3 - S9 in the same 
manner.  Prepulsed baseline impedance was measured horizontally and vertically in all sectors, 
using the pattern above before pulsing began in S1.  This pulsing regime was referred to as 4x4 
pulsing where each sector received a total of 8 pulses, four horizontal and four vertical. 
The second pulsing regime (impedance guided pulsing) did not use a fixed number of 
pulses.  EF pulsing continued in each sector until a predetermined impedance drop was attained 
relative to baseline impedance.  Interpulse impedance measurements were taken to evaluate 
response of tissue to EF pulses.  To assess precision and accuracy of hardware and the affect closed 
loop control had on DNA delivery, two relative impedance change values were evaluated:  80% 
and 95%.  Pulsing advanced sequentially through treatment sectors after a predetermined change 
(80% or 95%) in each sector impedance was attained.  The duration and interval of a single pulse 
was identical in both DEI and DEIF pulsing regimes however the number of pulses and time 
between advancement to each sector was different in DEIF groups as pulse number was guided by 
change in tissue impedance.  Because the pulse number was unique in all feedback groups, the 
total time required for a complete protocol in a single animal varied as well as the times for 
corresponding sectors between animals.  A single EF pulse was generated by a DC power supply 
with a duration of 150 ms and interval of 500 ms between pulses. 
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5.2.3 Treatment 
In this study white, mixed sex BALB/c mice (Charles Rivers) 8-10 weeks of age were used.  
Forty-eight hours before treatment the right flank of each animal was shaved.  Animals were 
shaved at this time point to allow healing of any minor abrasions that occasionally occur from 
clipping that might affect baseline impedance levels.  Immediately prior to treatment, animals were 
placed in an induction chamber under continuously supply of 2.5% isoflurane/97.5% oxygen 
mixture (Caliper Life Sciences).  Once completely anesthetized, animals were removed and 
attached to a standard scavenged nose cone under the same 2.5% isoflurane/97.5% oxygen mixture 
resting on a temperature controlled warming pad where they remained throughout pDNA injection 
the remainder of treatment. 
Eleven different treatment groups were established to compare the efficacy of different 
field strengths with either fixed or dynamic EF pulsing protocols to enhance the delivery of 
luciferase encoding plasmid.  A control group received neither a pDNA injection nor exposure to 
applied EF pulses.  To evaluate baseline uptake of pDNA that occurs without EF pulse exposure a 
second treatment group received an intradermal pDNA injection only (DO).  Nine treatment 
groups received intradermal pDNA injections and one of three different EF pulsing regimes in 
combination with one of three different field strengths.  Of these nine groups, three treatment 
groups received a pDNA injection followed by exposure to a fixed number of pulsed electric fields 
of either 100 V/cm, 150 V/cm, or 200 V/cm with impedance measurements taken before, during, 
and after pulses (DEI).  The six remaining groups received an intradermal pDNA injection 
followed by impedance controlled pulsation at a field strength of 100 V/cm, 150 V/cm, or 200 
V/cm that continued until treatment sector impedance dropped by either 80% or 95% (DEIF).  In 
DEIF groups, impedance measurements were taken before pulses to establish a baseline impedance 
47 
and after pulses to measure the change in impedance.  pDNA was administered as an intradermal 
bolus injection with a 1 cc syringe and a 30-gauge needle (BD).  Each injection contained 100 μg 
of gWiz Luciferase pDNA (Aldevron) in phosphate buffered saline, in an injection volume of 50 
μl. 
5.2.4 Biological Response, Quantification, and Statistical Analysis 
Successful transfection in treatment groups resulted in expression of luciferase reporter 
gene.  All treatment groups exhibited reductions in impedance after pulsed electric fields were 
applied, a surrogate for increased membrane permeability.  Generally, radiance increased as 
impedance decreased.  The amount of transfection present in each animal was determined from 
the detection of photons emitted by the luciferase-catalyzed reduction of injected luciferin 
substrate.  Luciferase enzyme was the protein product of the delivered reporter gene.  As the 
number of transfected cells or the number of reporter gene constructs delivered to a single cell 
increased, the concentration of luciferase increased.  To quantify radiance each animal was 
anaesthetized, as described above.  Once anaesthetized each animal received a 200 μl 
intraperitoneal injection of D-Luciferin at 15 mg/mL (Gold Biotechnology Inc.).  After injection, 
animals were kept anaesthetized, on a warming pad in a Xenogen IVIS 200 series imaging system 
(Caliper Life Sciences) for 15 minutes to allow transport of luciferin to the treatment site and for 
luminescence to reach a maximum.  At fifteen minutes, radiance (photon/s) was measured over a 
10-second exposure time.  This procedure was used to collect luciferin radiance 2, 4, 7, 10, and 14 
days post treatment.  Upon collection of data at all time points the mean radiance and standard 
error of the means for each group was calculated.  Statistical significance between groups was 
determined using a single-tailed Students t-test at a 95% significance level. 
48 
5.3 Results 
5.3.1 Gene Expression 
Figure 11 shows UV/VIS images of luciferin luminescence (photons/s) in a representative 
animal from each DEI, DEIF, and DO group 10 days post treatment.  Observable differences in 
the amount of delivery and area of successfully treated tissue between treatment groups were 
apparent.  Both luciferin luminescence and area of transfected tissue generally increased with 
electric field strength and stop impedance in all groups.  Image A in Figure 11, shows an animal 
that received a DNA injection only where luciferase expression was minimal as expected [88].  All 
DEIF groups (images C, D, F, G, I, and J) under feedback control showed marked increases in 
transgene expression above fixed pulse DEI (images B, E, and H) and the DO group.  Impedance 
based feedback groups not only showed the same dose response to field strength but also showed 
luciferin luminescence increased as targeted impedance drop increased.  Measurable expression of 
luciferase in the DO group was expected, as there is typically some uptake of plasmid by cells at 
the injection site more than likely associated with the shearing of cell membranes with the 
hypodermic needle during injection.  Radiance of control group animals that did not receive DNA 
injections or exposure to EF fields was also measured to establish baseline luminescence of healthy 
untreated tissue and found to be relatively negligible (not shown). 
Figure 12 shows mean luciferin luminescence data (photons/s) for all DO, DEI, and DEIF 
groups 2, 4, 7, 10, and 14 days post treatment.  Luciferin luminescence reached a maximum in all 
groups either by day 7 or 10 and began to approach background levels by day 14.  Luminescence 
levels for DO and DEI groups remained relatively level throughout the duration of the experiment 
starting at day 2 compared to DEIF groups.  The DO group exhibited lowest luciferin luminescence 
throughout the entire experiment.  In contrast to DO and DEI (non-feedback groups), all DEIF 
49 
groups showed a steep increase in luminescence beginning at day 4 that was not present in DEI 
and DO groups.  As expected, mean radiance and luciferase expression levels generally increased 
with field strength indicating an electric field mediated effect on delivery associated with field 
strength alone that contributed to increased permeability.  However, DEIF groups showed a 
marked increase in expression over DEI and DO groups when targeted relative impedance drops 
were used to guide EF pulse number.  This confirmed impedance was an acceptable surrogate for 
permeability.  Therefore, controlling GET pulse number to target relative impedance reductions 
also allowed for the controlled targeting of membrane permeability leading to enhanced DNA 
delivery. 
 
Figure 11:  Xenogen images of representative animals.  (A) DO group (B) 100 V/cm DEI group 
(C) 150 V/cm DEI group (D) 200 V/cm DEI group (E) 100 V/cm DEIF group at 95% (F) 150 
V/cm DEIF group at 95% (G) 150 V/cm DEIF group at 80% (H) 100 V/cm DEIF group at 80% 
(I) 200 V/cm group at 80% (J) 200 V/cm DEIF group at 95%. 
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Figure 12:  Mean luciferin luminescence for all groups 2, 4, 7, 10, and 14 post treatment. 
 
Table 2:  Mean luciferin luminescence for all groups at 2, 4, 7, 10, 14, and 30 days post 
treatment. 
 Mean Luciferase [ x 108 photon/sec ] 
Group Day 2 Day 4 Day 7 Day 10 Day 14 
DEI-100 V/cm 1.83* 1.81* 3.84** 2.9 3.47* 
DEI-150 V/cm 2.3 1.88* 4.41** 3.82* 3.3 
DEI-200 V/cm  4.0 2.44* 5.02* 3.57* 1.8 
DEIF-100 V/cm at 80% 1.89* 2.12* 10.21** 8.55* 5.6 
DEIF-100 V/cm at 95% 1.2 1.68* 6.37** 6.9* 4.83* 
DEIF-150 V/cm at 80% 3.36* 3.41* 7.93** 7.42* 6.35* 
DEIF-150 V/cm at 95% 2.82** 2.16** 7.06** 8.96** 8.98** 
DEIF-200 V/cm at 80% 6.58** 5.67** 13.8** 20.62** 14.47* 
DEIF-200 V/cm at 95% 3.45** 2.82** 16.2** 24.28** 5.58* 
* sig. at p<0.05; **sig. at p < 0.01 compared to injection alone. 
 
Table 2 shows the one tailed student t-test p values (α = 0.05) comparing DEI and DEIF 
group mean radiance to the DO group.  At day 7 all DEI and DEIF groups exhibited statistically 
higher mean radiance relative to DO group.  Peak mean radiance relative to the DO group was 
highest for all DEI and DEIF groups by day 7 or 10.  Figure 12 shows the greatest relative 
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expression levels was produced with 200 V/cm field strength pulses in DEIF groups targeting 80% 
and 95% stop impedances which exhibited statistically higher  11.6 (p value = 0.005 ) and 13.7 (p 
value = 0.006) fold increases in mean radiance relative to DO group at day 10.  Radiance in these 
DEIF groups remained statistically higher than DO group for fourteen days post treatment.  
Comparison of 200 V/cm DEIF groups targeting 80% and 95% impedance reduction with the non-
feedback 200 V/cm DEI group showed statistically greater radiances in DEIF groups that was 5.2 
and 6.8 fold higher respectively at day 10.  The statistically enhanced transfection present in the 
200 V/cm DEIF groups suggests impedance may accurately quantify the relative changes in 
membrane permeability associated with electric pulse stimulation.  In theory, a reduction in tissue 
impedance indicates the presence of new conductive pathways in tissue.  Within the epidermis and 
dermis cell membranes act as the primary barriers to current flow, therefore decreases in 
impedance may indicate when new current pathways through these barriers are present.  These 
results support that forcing reductions in membrane impedance with EF pulses as a method for 
ensuring maximum DNA transfection occurs consistently during GET.  Although the 200 V/cm 
DEIF 95% stop impedance group showed a higher mean radiance than the 200 V/cm DEIF 80% 
stop impedance group, they were not statistically different.  Considering the magnitude of the 
inherent variability in the biological response data, it was expected that increasing sample size 
might provide for a statistical difference in delivery between the DEIF groups targeting 80% and 
95% reductions in tissue impedance.  Increases in radiance were seen in lower field strength 
feedback groups relative to the DO group, although to a lesser degree.  The 100 V/cm DEI and 
DEIF groups targeting 8%0 and 95% impedance reduction exhibited mean radiances 3.0, 8.0, and 
5.0 fold higher relative to the DO group respectively at day 10.  The 150 V/cm DEI and DEIF 
groups targeting 80% and 95% impedance reduction exhibited greater mean radiances that were 
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3.5, 6.2, and 5.6 fold higher relative to the DO group respectively.  Again, in these lower field 
strength groups, mean radiance of 80% and 95% DEIF groups of the same field strength were not 
statistically different. 
 
 
 
Figure 13:  Mean luciferin luminescence at days 2, 4, 7, 10, and 14 days post treatment for DEI 
and DEIF groups.  (A) 100 V/cm (B) 150 V/cm and (C) 200 V/cm. 
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To assess the effect of permeability associated with 80% and 95% stop impedances on 
delivery, the contribution of field strength to delivery must be held constant.  Figure 13 shows 
radiance versus time for DEI and DEIF groups that received EF pulses of the same field strength.  
All DEIF groups exhibited statistically higher mean radiance when compared to DEI groups of the 
same field strength where α = 0.05.  Mean radiance of 100 V/cm DEIF groups targeting 80% and 
95% stop impedances (Figure 13A) were 3.0 (p value = 0.041) and 2.4 (p value = 0.025) fold 
higher relative to 100 V/cm DEI group respectively at day 10.  Mean radiance of 150 V/cm DEIF 
groups targeting 80% and 95% stop impedances (Figure 13B) were 2.1 (p value = 0.043) and 2.5 
(p value = 0.024) fold higher relative to 150 V/cm DEI group respectively at day 10.  Mean 
radiance of 200 V/cm DEIF groups targeting 80% and 95% stop impedances (Figure 13C) were 
5.2 (p value = 0.012) and 6.8 (p value = 0.011) fold higher relative to 200 V/cm DEI group 
respectively at day 10.  However, there was no statistical difference in mean radiance between any 
80% and 95% feedback groups of the same field strength.  Considering mean radiance in all 95% 
DEIF groups was higher than 80% DEIF groups of the same field strength, it is expected further 
testing with larger sample sizes may reveal there is a statistical difference between these groups.  
These increases in mean radiance between feedback groups and non-feedback groups of the same 
field strength underscore the potential utility of impedance spectroscopy to enhance gene delivery 
during GET.  The lower field strength, 100 V/cm and 150 V/cm, 80% and 95% feedback groups 
on average produced respective radiances 2.4 and 2.3 fold higher than the non-feedback group of 
the same field strength.  The 200 V/cm feedback groups on average produced radiances 6.3 fold 
higher than the non-feedback 200 V/cm group.  This suggests the membrane permeability resulting 
from EF stimulation was dependent on both field strength and relative change in impedance.  
Targeting a higher relative impedance reduction near 99% may provide for statistically enhanced 
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delivery above the 80% DEIF groups.  The significantly higher delivery in DEIF groups indicates 
the utility of interpulse impedance measurements to evaluate cell response to EF pulses.  This 
information is ideal for use in optimizing EF pulse number to achieve the membrane permeability 
necessary for ensuring DNA uptake upon every application of a GET protocol. 
 
 
Figure 14:  Mean luciferin luminescence at days 2, 4, 7, 10, and 14 days post treatment for 100 
V/cm, 150 V/cm, and 200 V/cm DEIF groups.  Stop impedances of (A) 80% and (B) 95%. 
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membrane permeability, it was logical to expect that tissues with relatively equal reductions in 
impedance would have roughly equal permeabilities however this was not the case.  In DEIF 
groups targeting an 80% impedance reduction, pDNA delivery was not statistically different 
between 100 V/cm and 150 V/cm DEIF groups.  However, radiance in the 200 V/cm, 80% DEIF 
group was greater than the radiance in the 100 V/cm and 150 V/cm 80% DEIF groups.  This result 
was also present in the 95% DEIF groups.  Figure 14A shows the 200 V/cm, 80% DEIF group 
radiance was 2.4 (p value = 0.041) and 2.8 (p value = 0.027) fold higher than the 100 V/cm and 
150 V/cm 80% DEIF groups at day 10 respectively.  Figure 14B shows the 200 V/cm, 95% DEIF 
feedback group radiance was 3.5 (p value = 0.018) and 2.7 (p value = 0.029) fold higher than the 
100 V/cm and 150 V/cm 95% DEIF groups at day 10 respectively.  These groups targeted the same 
reduction in impedance, a measurement of cellular response to the electric field, but exhibited 
differences in pDNA indicating the quality of permeability may be field strength dependent.  The 
quality of membrane permeability refers to the number and size of membrane discontinuities 
contributing to new current pathways and changes in impedance.  For example, a greater number 
of permeabilized regions of membrane with smaller diameters could provide an equal quantity of 
current through a cell as a fewer number of permeabilized regions with larger diameters.  Models 
have been suggested that predict the rate of evolution, diameter, and number of membrane 
discontinuities are a function of electric pulse duration and magnitude [89] [90].  This data supports 
these models; the quality of membrane permeability may be dependent on field strength and an 
integral component of GET that warrants consideration.  If this was the case and these transient 
pores facilitated transfection then regions of the membrane that become permeabilized must 
remain permeable long enough for DNA transport to occur.  In addition, these permeabilized 
regions must also be large enough for supercoiled DNA to translocate through these permeabilized 
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regions.  Investigating the quality of membrane permeability may be possible to resolve with more 
advanced spectroscopic techniques but was beyond the scope of this investigation.  The results in 
Figure 14 could also be explained by a different GET mechanism.  Other researchers have 
proposed that GET occurs because of an active cellular/biological response that is induced by 
electric field stimulation where the strength of the electric field determines the magnitude of the 
response [67].  This purportedly involves pDNA binding to cell membranes followed by 
endocytosis-like uptake.  Regardless of the mechanism, Figure 15 results imply the quality of 
permeability is a critical variable that effects DNA delivery. 
5.3.2 Pulse Number, Electrode Effects, and Stop Impedance 
Although tissue architecture between the same regions in different animals or organisms 
has the same overall structure with respect to cell types and matrix components there exists 
variation between the geometric distributions of these entities essentially creating unique 
anisotropic microenvironments that respond differently to EF pulses [91].  It has been shown that 
even cell morphology can significantly affect electric properties of tissue [92].  Skin Hydration 
was another factor that contributed to tissue architecture and chemistry that in turn affected how 
tissues responded to electric field stimulation.  Certain pathologies, general health status and 
exterior air humidity have been shown to affect stratum corneum thickness [93] [94].  The impact 
of these factors on electrical properties of treated skin were evident in all DEIF groups.  The 
number and distribution of pulses was unique for all animals in DEIF groups, a result of anisotropic 
tissue architecture, chemical makeup of treated skin, electrode reuse, and pulse sequence.  These 
factors underscored the need for the integration of feedback control mechanisms in GET methods.  
This was apparent in animals that received the identical treatment conditions where the same 
treatment sectors required a different number of pulses.  As expected differences between pulse 
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number in animals receiving identical treatment conditions were significantly smaller than 
differences between animals in other groups.  Variations in sector pulse number and total pulse 
number between animals of the same group where treatment occurred on different days was 
identified as a possible inconsistency in experimental setup or GET execution.  This resulted in an 
inflation of sector pulse number and total pulse number in the first four animals in each treatment 
group.  The twelve animals in each treatment group were broken into three separate experiments 
in groups of four where animals 1 through 4 were treated separately on a different day than animals 
5 through 12, which received treatment on the same day.  This may explain the obvious variation 
in the number of pulses required to reach targeted stop impedances in each sector between the first 
four animals and animals 5 through 12 in each group.  Differences in experimental setup involving 
different electrode tips, fouling of electrodes, and or differences in protocol execution such as 
electrode contact quality between experiments performed on separate days may have been the 
source of this variation.  However, the pulse number trends per animal in the inflated groups 
(animals 1-4) mirrored the same trends in animals 5 through 12. 
The pulse number required to reach or exceed the target stop impedance as previously 
mentioned was expected to be a function of differences in tissue architecture, and electrode contact 
quality.  However, experimental results also revealed a distinct pattern in the distribution of electric 
pulses each treatment sector required when pulsing was driven by impedance changes.  This 
pattern was consistent in all feedback groups and was a function of 2 electrode design/protocol 
aspects:  electrode geometry and pulse sequence progression through the electrode array.  With 
respect to electrode geometry, the extension of electric fields from sectors being directly pulsed 
into adjacent sectors and the reuse of common electrodes shared between adjacent sectors 
contributed to patterns in the ease with which impedance was lowered in some sectors relative to 
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others.  During GET pulses, electric fields were not strictly contained within the treatment sectors 
but also extended into adjacent sectors.  It appeared that fringe fields generated by GET pulses in 
upstream sectors increased the permeability in adjacent downstream sector tissue, which decreased 
impedance in downstream sectors further from baseline before being directly pulsed.  As a result, 
the number of pulses required to reach the targeted stop impedance was reduced in downstream 
sectors and in sectors where electrode reuse was greatest.  This pattern in pulse number was 
generally consistent throughout all DEIF groups but became less prevalent as field strength 
increased.  The reuse of common electrodes in treatment sectors provided for a significant 
cumulative effect in most downstream sectors.  For example, at least one of the 4 electrodes 
defining sector 5 was used in every pulse prior to being pulsed directly.  As a result, sector 5 
consistently required the fewest number of pulses in all feedback groups and exhibited the greatest 
reduction in impedance of all sectors in all groups.  In contrast, the first sector (S1) to receive 
pulsing generally required more pulses than other sectors because tissue in this sector was the first 
to be pulsed and therefore effects associated with electrode reuse or neighboring sector pulses was 
not present.  The time and distance between indirect and direct pulses was another critical factor 
contributing to the collective effect of the electrode array geometry and pulse progression on 
patterns in sector impedance.  The duration between indirect and direct pulses in a sector was 
longer in lower field strength groups because they required a greater number of pulses compared 
to the 200 V/cm groups which required a significantly fewer number pulses.  Effects associated 
with this were most apparent in the reduced change in impedance seen in sectors 1, 4, and 7.  This 
may have allowed impedance to relax more before direct pulsing therefore reducing the impact of 
fringe fields in these sectors. 
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Table 3 shows the mean pulse number per sector and total pulse number for each animal 
in the 100 V/cm field strength DEIF group targeting a stop impedance of 80%, reported with peak 
radiance for each animal.  Considering the central location of sector five and because it is the only 
sector that shared at least one electrode during every pulse, it was expected it would correlate best 
with gene delivery success.  Table 3 shows sector 5 received the fewest mean number of pulses or 
was tied for the fewest number of pulses in all animals with a group mean of 4 pulses.  The number 
of pulses required in sector 5 was the least variable with a standard deviation of 2.  These results 
reinforced the effect upstream pulses and electrode reuse had on reducing membrane permeability 
in downstream sectors.  The reuse of upstream electrodes common to sector 5 may have initiated 
the permeabilization mechanism and reduced impedance in this sector before receiving direct 
pulsing accounting for the observed reduction in pulses.  Pulse number was greater for sectors in 
the corners of the array (S1, S3, S7, and S9) where corner electrode reuse was the lowest.  This 
resulted in these sectors receiving the most pulses, requiring a mean of 24 pulses between.  Sectors 
2, 4, 6, and 8 formed a second tier of sectors that generally required an intermediate mean number 
of 8 pulses.  In this treatment group, corner sector 7 required a mean of 24 pulses, the most of any 
sector, which was also the most variable with a standard deviation of 14 pulses.  The maximum 
number of pulses in each sector was 40; therefore, it was assumed that sectors that received 40 
pulses might have not achieved stop impedance.  For this group, the mean total number of pulses 
was 93 with a standard deviation of 60.  The high variability in the total pulse number exhibited in 
this group was more than likely a result of differences in the setup and execution of experiments 
occurring on different days.  There also appeared to be no correlation between total pulse number 
and radiance, supporting that differences in tissue architecture contribute to pulse number 
requirements, but it is impedance changes and permeability that more closely indicate magnitude 
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of delivery.  Evidence of closed loop pulsing to compensate for electrode geometry was 
consistently supported by the disparity of required pulses between peripheral and central sectors. 
Table 3:  Sector pulse number, total pulse number, and peak radiance per animal in 100 V/cm 
DEIF group targeting 80% stop impedance.  Red sectors received maximum number of pulses. 
Animal S1 S2 S3 S4 S5 S6 S7 S8 S9 Total Pulse # Peak Radiance 
1 18 6 24 12 6 20 40 34 40 200 1.59E+08 
2 20 8 16 22 6 14 40 34 20 180 1.31E+08 
3 12 4 18 18 2 8 40 34 20 162 1.14E+08 
4 16 10 16 28 6 10 40 2 4 132 2.20E+08 
5 24 4 6 2 2 2 6 2 2 50 3.31E+09 
6 2 2 2 2 2 2 20 2 2 36 6.01E+08 
7 2 2 2 4 2 4 4 2 8 30 4.93E+08 
8 2 2 2 4 2 2 20 2 2 38 4.22E+08 
9 4 4 6 12 2 4 12 4 6 54 3.08E+09 
10 6 8 10 6 4 4 34 4 16 92 1.80E+09 
11 2 2 14 4 2 2 20 2 10 58 1.09E+09 
12 14 10 16 14 6 4 14 2 2 82 8.87E+08 
̅ݔ 10 5 11 11 4 6 24 10 12 93 1.03E+09 
σ 8 3 7 9 2 6 14 13 13 60 1.12E+09 
 
 
Table 4:  Sector pulse number, total pulse number, and peak radiance per animal in 100 V/cm 
DEIF group targeting 95% stop impedance.  Red sectors received maximum number of pulses. 
Animal S1 S2 S3 S4 S5 S6 S7 S8 S9 Total Pulse # Peak Radiance 
1 40 40 36 40 2 24 40 40 40 302 6.56E+08 
2 40 40 40 40 20 40 40 40 40 340 1.53E+08 
3 40 40 40 40 18 40 40 40 32 330 1.69E+08 
4 40 40 40 40 12 40 40 40 40 332 1.88E+08 
5 22 6 8 4 2 4 40 2 6 94 9.39E+08 
6 32 4 20 14 2 4 40 12 16 144 4.87E+08 
7 8 4 4 8 2 6 40 6 10 88 4.43E+08 
8 16 6 18 16 2 2 16 4 6 86 1.58E+08 
9 26 34 40 40 8 10 40 12 14 224 2.00E+09 
10 40 6 26 18 4 6 40 14 14 168 1.85E+09 
11 40 16 40 18 14 14 40 8 40 230 1.12E+09 
12 32 10 22 36 8 12 40 16 36 212 6.93E+08 
̅ݔ 31 21 28 26 8 17 38 20 25 213 7.38E+08 
σ 11 17 13 14 7 15 7 16 15 98 6.38E+08 
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Table 4 shows mean pulse number per sector and total pulse number for each animal in the 
100 V/cm field strength DEIF group targeting a stop impedance of 95%, reported with peak 
radiance for each animal.  Again, sector 5 required the fewest number of pulses in every animal 
with a group mean of 8 pulses.  This was evidence of the effect upstream pulses had on reducing 
membrane permeability in downstream sectors.  The reuse of upstream electrodes common to 
sector 5 initiated the permeabilization mechanism and reduced impedance in this sector before 
being directly pulsed.  However, because stop impedance was increased more pulses were needed 
in each sector compared to the 80% stop impedance group of the same field.  Table 4 indicates a 
large number of sectors received the maximum number of 40 pulses and may not have or were 
very near reaching targeted impedance reduction.  The lower field strength in this group was unable 
to generate the permeability needed to produce a 95% reduction in impedance in all sectors.  Table 
4 shows generally eight out of nine sectors in the first four animals were near or did not reach the 
stop impedance accept for the centrally located sector 5, evidence of possible differences in 
experimental setup.  This was not the case in animals 5 through 12.  Additionally, sector 7 in all 
but one animal in this group required 40 pulses indicating this sector was most resistant to the 
electrode effects associated with electrode reuse, indirect pulses, and electric pulse progression.  
Sector 7’s resistance to these effects prevented any marked impedance reduction before being 
directly pulsed.  Again, pulse number was greatest for corner sectors of the array (S1, S3, S7, and 
S9) where electrode reuse was the lowest.  These sectors required a mean of 31 pulses.  Sectors 2, 
4, 6, and 8 again formed the second tier of sectors requiring an intermediate number of pulses with 
a mean of 21 pulses.  Electrode reuse was higher in these groups thus, they required fewer direct 
pulses.  The mean total number of pulses for this group was 213 with a standard deviation of 98, 
a mean increase of 120 pulses compared to the DEIF 80% stop impedance group of the same field 
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strength.  Again, variability was due to differences in experimental setup and execution that 
occurred between two separate experiments as well as differences in tissue architecture between 
animals.  Table 4 shows many sectors received the maximum number of pulses indicating the 
minimum targeted impedance and corresponding permeability was not achieved in many sectors.  
Therefore, it was expected that GET delivery was not homogeneous throughout all treatment 
sectors in these animals.  As a result, this protocol would not have been considered successful 
based on the possible lack of achieving targeted impedance reduction in all sectors even though 
delivery and transgene expression was greater than the DEI group of the same field strength.  In 
the future, to ensure target impedance and a permeability is homogeneous in all sectors the 
maximum number of pulses must be increased when using 100 V/cm pulses to target a 95% 
reduction in tissue impedance. 
Table 5 shows mean pulse number per sector and total pulse number for each animal in the 
150 V/cm DEIF group targeting a stop impedance of 80%, reported with peak radiance for each 
animal.  The mean pulse number per sector in this group was significantly lower in all sectors 
when compared to lower field strength groups.  This was result of the increased field strength 
applying a greater force on ions so that cell membrane charging and potential increased a greater 
amount per pulse causing dielectric breakdown and permeabilization to occur more quickly.  Many 
animals required only 2 pulses in every sector except for sector 7.  This low pulse requirement was 
also a result of a reduction in the rate at which pulsing advancement though sectors.  These faster 
advancing sequences enhanced the permeabilizing effects of indirect pulsing in downstream 
sectors because the impedance in downstream sectors had less time to decay before being directly 
pulsed.  Table 5 shows sector 5 required a mean of only 2 pulses, the fewest in every animal, 
supporting the effect electrode reuse and indirect pulsing had on reducing membrane permeability 
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in downstream sectors.  Pulse number was still greater for sectors in the corners (S1, S3, S7, and 
S9) of the array and sector 4 where indirect pulsing and corner electrode reuse was lower.  This 
resulted in these sectors requiring more pulses with a mean of 7 pulses.  Sectors 2, 6, and 8 
generally formed the second tier of sectors that required an intermediate mean number of 3 pulses.  
However this mean number of was much closer to the mean number of pulses in the centrally 
located sector 5 indicating electrode effects at this higher field strength and lower stop impedance 
were less prevalent.  This also meant differences in treatment sector permeabilities were less 
variable.  This protocol was considered successful because all sectors in all animals having 
achieved targeted impedance reduction and corresponding permeability. 
Table 5:  Sector pulse number, total pulse number, and peak radiance per animal in 150 V/cm 
DEIF group targeting 80% stop impedance.  Red sectors received maximum number of pulses. 
Animal S1 S2 S3 S4 S5 S6 S7 S8 S9 Total Pulse # Peak Radiance 
1 6 2 14 8 2 4 20 4 6 66 1.03E+09 
2 6 6 8 6 2 2 26 2 20 78 1.50E+09 
3 14 4 6 10 2 6 40 2 8 92 1.68E+09 
4 16 8 10 20 2 2 4 4 10 76 3.85E+08 
5 4 2 2 2 2 2 4 2 2 22 2.04E+09 
6 2 2 2 2 2 2 6 2 2 22 1.27E+09 
7 2 2 2 2 2 2 12 2 2 28 1.21E+09 
8 2 2 2 2 2 2 2 2 2 18 6.57E+08 
9 2 2 2 2 2 2 4 2 2 20 2.06E+09 
10 2 2 8 6 2 2 12 2 8 44 1.04E+09 
11 2 2 2 4 2 2 4 2 6 26 1.09E+09 
12 2 4 8 2 2 2 4 2 2 28 3.07E+08 
̅ݔ 5 3 6 6 2 3 12 2 6 43 1.19E+09 
σ 5 2 4 5 0 1 12 1 5 27 5.71E+08 
 
Table 6 shows mean pulse number per sector and total pulse number for each animal in the 
150 V/cm field strength DEIF group targeting a stop impedance of 95%, reported with peak 
radiance for each animal.  Mean pulse number per sector increased in all animals when compared 
to the lower 80% stop impedance group of the same field strength.  Targeting a higher 95% stop 
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impedance required more pulses of the same field strength to reduce tissue impedance to a greater 
degree.  Even though the targeted change in impedance was increased, fewer animals had sectors 
that required maximum number of pulses or did not reach stop impedance when compared to the 
lower 100 V/cm field strength group with the same stop impedance.  As expected, sector 5 received 
the fewest mean number of pulses in every animal with a group mean of 3 pulses with low 
variability as shown by a standard deviation of 1.  This was evidence of the effect electrode reuse 
and upstream pulses had on reducing membrane permeability in downstream sectors.  Pulse 
number was still greater for sectors in the corners of the array (S1, S3, S7, and S9) and sector 4 
where corner electrode reuse was the lowest.  This resulted in these sectors receiving more pulses, 
requiring a mean of 20 pulses.  Sectors 2, 6, and 8 generally formed the second tier of sectors that 
required an intermediate mean number of pulses with a mean of 7 pulses.  In contrast to the lower 
80% stop impedance, DEIF group of the same field strength there was greater variation in pulse 
number in peripheral sectors.  This greater number of pulses was a result of the increase in targeted 
reduction in impedance that amplified differences in tissue architecture and electrode effects.  
Sectors 1 and 7 required the greatest number of pulses with means of 28 and 25 respectively.  In 
order to reduce impedance to 95%, a greater number of pulses was required as compared to the 
80% group at the same field strength.  Table 6 shows 150 V/cm field strength pulses were strong 
enough to achieve the targeted impedance reduction within 40 pulses in most animals.  Excluding 
animals 1 through 4, all treated tissue in animals 5 through 12 achieved the targeted impedance 
reduction and corresponding membrane permeability leading to delivery that was more 
homogeneous across sectors.  Even though delivery in this group was statistically greater than the 
DEI group at 150 V/cm, this protocol was not considered successful because the impedance and 
permeability in many sectors did not reach targeted values due to pulse number limitations.  
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Maximum pulse number must be greater than 40 when targeting 95% stop impedance with 150 
V/cm electric pulses to ensure targeted permeability is achieved in all sectors when using this 
electrode and protocol.  However, the distribution of pulses between low and high electrode use 
sectors showed this feedback method was able to compensate for electrode geometry and pulse 
sequence effects. 
 
Table 7 shows mean pulse number per sector and total pulse number for each animal in the 
200 V/cm field strength DEIF group targeting a stop impedance of 80%, reported with peak 
radiance for each animal.  The increased field strength in these animals significantly reduced the 
mean number of pulses per sector to the lowest values of any DEIF group.  This trend supports the 
premise that higher field strength pulses charged cell membranes more quickly by moving more 
charge with a fewer number of pulses.  More charges were moved because of the greater force 
imposed on each ion by the higher magnitude electric fields in the extracellular and intracellular 
compartments.  As a result, membrane permeability also increased when membranes were charged 
Table 6:  Sector pulse number, total pulse number, and peak radiance per animal in 150 V/cm 
DEIF group targeting 95% stop impedance.  Red sectors received maximum number of pulses. 
Animal S1 S2 S3 S4 S5 S6 S7 S8 S9 Total Pulse # Peak Radiance 
1 40 10 24 40 6 18 40 4 28 210 1.6E+09 
2 40 18 26 40 2 4 38 4 16 188 1.7E+09 
3 40 24 26 10 2 6 40 4 20 172 3.5E+08 
4 40 12 32 40 4 10 40 6 20 204 2.2E+08 
5 32 2 16 8 2 2 14 2 8 86 2.2E+09 
6 12 2 6 8 2 2 2 2 2 38 1.2E+09 
7 8 6 4 4 2 4 6 4 6 44 1.9E+09 
8 40 6 12 8 2 6 16 6 4 100 4.3E+08 
9 14 10 14 10 2 2 36 4 8 100 1.6E+09 
10 16 4 16 12 2 4 8 2 10 74 1.4E+09 
11 36 24 26 2 2 2 14 2 2 110 6.0E+08 
12 14 12 8 6 2 4 40 6 16 108 4.8E+08 
̅ݔ 28 11 18 16 3 5 25 4 12 120 1.26E+09 
σ 13 8 9 15 1 5 16 2 8 60 6.8E+08 
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to a greater degree because the breakdown potential of the lipid bilayer was exceeded by a greater 
extent in a shorter period.  The mean number of pulses in all sectors was 2 or 3.  The effect of 
upstream pulses on lowering impedance in downstream sectors was not assessable because the 
protocol required each sector receive at least one pulse regardless of the impedance drop that 
occurred before direct pulsing.  By the time pulsing advanced to sector 5, it was likely that 
impedance had been reduced by 80% due to electrode reuse and indirect pulses, but one pulse was 
still required in the protocol as a practical safeguard to ensure delivery occurred.  200 V/cm pulses 
abolished the resistance of sector 7 to impedance reductions at this lower stop impedance requiring 
a mean of 3 pulses.  The highest 200 V/cm field strength electric pulse may be a better choice for 
cutaneous GET as it was able to generate targeted impedance reductions in all sectors within a 
fewer number of pulses with less variability.  The permeability associated with the 80% impedance 
reduction achieved in all treatment sectors in all animals in this group likely accounted for the 6-
fold increase in radiance relative the DEI group of the same field strength.  Radiance in this group 
was also the second highest (12 fold) relative to the DO group.  As a result, this protocol was 
considered successful and identified that the permeability associated with a targeted minimum 
impedance reduction of 80% achieved with 200 V/cm electric pulses was of a different quality 
than lower field strength groups targeting the same impedance reduction. 
Table 8 shows mean pulse number per sector and total pulse number for each animal in the 
200 V/cm field strength DEIF group targeting a stop impedance of 95%, reported with peak 
radiance for each animal.  A minimal overall increase in pulses was required to achieve target stop 
impedances when compared to the lower 80% stop impedance group of the same field strength.  
Sectors 2, 5, 6, and 8, where electrode reuse was higher, required the fewest number of pulses, a 
mean of 3, to reach the 95% stop impedance compared to other sectors.  This continued to support 
67 
the effect upstream pulses had on reducing membrane permeability in downstream sectors.  Corner 
sectors 1, 3, 7, and 9, as well as sector 4, where electrode reuse was lower, required a mean number 
of 8 pulses.  Table 8 shows 200V/cm field strength pulses were strong enough to achieve the 
targeted impedance reduction within 40 pulses in all sectors.  Because of this, it was expected the 
targeted impedance reduction and corresponding membrane permeability was achieved in all 
sectors.  This protocol was the most successful and identified that the permeability associated with 
a minimum impedance reduction of 95% achieved with 200 V/cm electric pulses was of a different 
quality than lower field strength groups targeting the same impedance reduction.  This quality was 
responsible for the 7 fold increase in expression relative to the 200 V/cm DEI group.  Although 
radiance in this group was not statistically greater than the 200 V/cm, 80% stop impedance DEIF 
group, it is expected that a greater sample size would show the permeability associated with 95% 
impedance reduction does produce a statistically greater amount of delivery. 
 
Table 7:  Sector pulse number, total pulse number, and peak radiance per animal in 200 V/cm 
DEIF group targeting 80% stop impedance.  Red sectors received maximum number of pulses. 
Animal S1 S2 S3 S4 S5 S6 S7 S8 S9 Total Pulse # Peak Radiance 
1 2 2 2 2 2 2 4 2 2 20 3.7E+09 
2 4 2 4 4 2 2 4 2 4 28 4.7E+09 
3 4 2 4 6 2 2 6 2 4 32 2.5E+09 
4 4 2 2 4 2 2 4 2 2 24 1.4E+09 
5 2 2 2 2 2 2 2 2 2 18 4.3E+09 
6 2 2 2 2 2 2 2 2 2 18 3.2E+09 
7 2 2 2 2 2 2 2 2 2 18 7.4E+08 
8 2 2 2 2 2 2 2 2 2 18 6.5E+08 
9 2 2 2 2 2 2 2 2 2 18 1.8E+09 
10 4 2 4 2 2 2 2 2 2 22 2.0E+09 
11 2 2 2 2 2 2 2 2 2 18 7.7E+08 
12 2 2 2 2 2 2 2 2 2 18 2.6E+08 
̅ݔ 3 2 3 3 2 2 3 2 2 21 2.2E+09 
σ 1 0 1 1 0 0 1 0 1 5 1.5E+09 
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Table 9 shows the mean total pulse number per group, and the mean peak radiance for the 
six DEIF groups.  In feedback groups with EF pulses of the same field strength, the mean total 
number of pulses increased with targeted stop impedance.  The mean total pulse number in the 100 
V/cm DEIF groups increased from 93 to 213 when stop impedance was increased from 80% to 
95%.  Similarly, the mean total pulse number in the 150 V/cm DEIF groups increased from 43 to 
120 when stop impedance was increased from 80% to 95%.  Lastly, the mean total pulse number 
in the 200 V/cm DEIF group increased from 11 to 21 when stop impedance was increased from 
80% to 95%.  Interestingly, there was a roughly 50% reduction in the mean total pulse number 
when stop impedance was increased from 80% to 95% in groups of the same field strength 
indicating a possible linear relationship may exist within this range of excitation.  The differences 
in pulse number between animals in the same group and animals of the same field strength 
targeting different stop impedances can be explained.  For animals in the same group, when 
keeping field strength constant each pulse exerted the same force on intra and extra cellular ions.  
However, differences in tissue architecture and ion concentration effected the number of pulses 
required to move the roughly same amount of ions needed charge membranes to the same degree 
in order to attain the targeted stop impedance.  This accounted for the variation in pulse number 
required to reach the same target impedance drop in animals of the same group.  For animals in 
different stop impedance groups of the same field strength, it was expected that after ions had 
charged the cell membrane in response to EF pulses, the transmembrane potential in a portion of 
membrane exceeded the breakdown potential inducing permeabilization.  Therefore, tissues 
targeting the same impedance drop should have roughly similar degrees of membrane permeability 
across sectors with correspondingly similar radiances.  When stop impedance was increased, more 
pulses were required to move more ions to increase the membrane potential over a greater area of 
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the cell, which may have led to a greater amount of delivery as was indicated by a greater reduction 
in impedance.  When holding stop impedance constant and comparing groups of different field 
strengths, mean total pulse number decreased with field strength again supporting the presence of 
an EF dose response.  Table 9 shows that in feedback groups targeting a stop impedance of 80% 
the mean total pulse number was 93, 43, and 21 for 100 V/cm, 150 V/cm and 200 V/cm EF pulse 
strengths respectively.  In DEIF groups targeting a stop impedance of 95%, mean total pulse 
number was 213, 120, and 51 for 100 V/cm, 150 V/cm and 200 V/cm EF pulse field strengths 
respectively.  The reduction in pulse number can be explained.  A greater field strength pulse 
imposed a greater amount of force on ions inside and outside the cell therefore moving more ions 
and charging a greater degree of membrane to a higher membrane potential.  Ultimately, as the 
membrane continued to charge the breakdown voltage was eventually exceeded, inducing 
permeability within a fewer number of pulses.  This was shown in Table 9 where total pulse 
number decreased by roughly 50% for every 50 V/cm increase in field strength. 
 
Table 8:  Sector pulse number, total pulse number, and peak radiance per animal in 200 V/cm 
DEIF group targeting 95% stop impedance.  Red sectors received maximum number of pulses. 
Animal S1 S2 S3 S4 S5 S6 S7 S8 S9 Total Pulse # Peak Radiance 
1 28 2 8 12 2 2 28 4 6 92 1.5E+09 
2 20 2 6 8 2 2 8 4 6 58 4.7E+09 
3 8 4 10 2 2 2 14 2 4 48 2.4E+09 
4 40 12 8 12 2 4 36 2 8 124 3.9E+09 
5 6 2 2 6 2 2 2 2 2 26 7.6E+09 
6 2 2 2 2 2 2 2 2 2 18 4.3E+09 
7 10 2 4 6 2 2 4 2 2 34 1.7E+09 
8 6 2 4 4 2 2 2 2 2 26 4.4E+08 
9 10 2 6 12 2 2 6 2 2 44 2.7E+09 
10 8 2 4 8 2 2 6 2 6 40 Deceased 
11 10 4 4 8 2 2 4 2 2 38 1.1E+09 
12 20 4 2 10 2 6 12 2 2 60 Deceased 
̅ݔ 14 3 5 8 2 3 10 2 4 51 3.0E+09 
σ 11 3 3 4 0 1 11 1 2 30 2.1E+09 
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It was expected that animals, which achieved the same impedance reduction per sector, 
should have had generally equal amounts of membrane permeability regardless of field strength 
and corresponding radiances that were also roughly equal, however this did not occur.  Mean 
radiance of the 200 V/cm, 80% and 95% stop impedance DEIF groups was significantly greater 
than lower field strength groups targeting the same impedance reduction.  In groups targeting an 
80% stop impedance, the 200 V/cm field group mean peak radiance was 2.4 and 2.8 fold greater 
than the 100 V/cm (p value = 0.041) and the 150 V/cm group (p value = 0.027).  In groups targeting 
a 95% stop impedance, the 200 V/cm field group mean radiance was 3.5 and 2.7 fold greater than 
both the 100 V/cm (p value = 0.018) and the 150 V/cm group (p value = 0.029).  This was an 
unexpected yet insightful result that implied field strength must still be one of the critical variables, 
along with impedance reduction, responsible for producing the quality of permeability optimum 
for DNA delivery.  Field strength may determine the quality of membrane permeability with 
respect to the number and diameter of permeabilized sites.  Higher field strengths may produce a 
fewer number of larger discontinuities within the membrane, whereas lower field strength pulses 
may induce a greater number of smaller membrane discontinuities while each case still produces 
similar changes in impedance.  This difference in the quality of permeability may allow for greater 
direct transport of DNA or stimulated uptake of DNA by the cell.  Regardless of the mechanism, 
the quality of membrane permeability created by 200 V/cm electric pulses was significantly 
different from that created by the lower by 100 V/cm and 150 V/cm pulses and was critical in 
enhancing DNA uptake. 
Another variable to consider that may account for differences in the radiance of different 
field strength groups targeting the same stop impedance was the change in membrane permeability 
that occurred in sectors after direct pulsing caused by the exposure to overlapping fields in 
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downstream sectors.  The unmeasured change in impedance occurring in sectors already pulsed 
was not known.  It was highly likely that impedance in earlier pulsed sectors continued to decrease 
below the target stop impedance because of exposure to overlapping fields from adjacent 
downstream sectors and electrode reuse.  This may have contributed to an increase in radiance.  
For example, it was highly likely that the actual impedance change experienced by sector 5 at the 
end of the protocol was greater than the target stop impedance because of pulsing in adjacent 
downstream sectors 6, 7, 8, and 9.  Considering this, it was likely that sector 9 was the only sector 
to have achieved targeted stop impedance and all other sectors would attain a final reduction in 
impedance that was greater than the stop impedance achieved by direct pulsing.  The protocol 
evaluated in this study could be described as having targeted a minimum change in impedance in 
treatment sectors.  Regardless, optimizing pulse number to target a minimum impedance reduction 
in all sectors still contributed to significantly higher pDNA delivery.  Additional work must be 
done to identify the best stop impedance, and to develop an electrode design or different pulsing 
pattern with fewer elements that confound what is occurring in treated sectors. 
Table 9:  Mean total pulse number and mean peak radiance per treatment group. 
Field Strength + Stop Impedance Mean Total Pulse # Mean Peak Radiance 
100 Vcm + 80% 93 1.0E+09 
150 Vcm + 80% 43 1.2E+08 
200 Vcm + 80% 21 2.2E+09 
100 Vcm + 95% 213 7.4E+08 
150 Vcm + 95% 120 1.3E+09 
200 Vcm + 95% 51 3.0E+09 
 
Limitations in spatial resolution of radiance measurements precluded the analysis of the 
effect the number of applied pulses had on the radiance in each sector.  As a result, peak animal 
radiance versus total pulse number was used to establish whether a correlation existed between 
total pulse number and radiance.  To evaluate this, peak radiance of each animal in each group was 
plotted versus the total number of pulses that animal received.  Differences in metabolic status 
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resulted in peak radiance occurring at different time points for different animals.  Therefore, 
selecting peak radiance regardless of the day it occurred accounted for this and was necessary to 
capture any correlation between these two variables.  Figure 15 shows peak radiance per animal 
versus total pulse number for all DEIF groups.  With a sample size of N=12, Figure 15 shows there 
was no apparent relationship between pulse number and peak radiance in any DEIF group as was 
evident by the low coefficient of determination (R2) between these two variables in all groups.  
The DEIF group receiving the lowest field strength EF pulse of 100 V/cm targeting the lowest stop 
impedance of 80% had an R2 value of 0.2236 that was the greatest of any group.  The 100 V/cm 
at 95%, 150 V/cm at 80% and 95%, and the 200 V/cm at 80% groups had respective R2 values of 
0.0414, 0.0018, 0.0860, and 0.1258.  The lowest R2 of 0.0014 was present in the DEIF group 
receiving the greatest field strength pulse of 200 V/cm targeting the greatest stop impedance of 
95%, which had an R2 value of 0.0014.  This group also exhibited the greatest mean radiance of 
any group.  All DEIF groups exhibited a generally random distribution of peak mean radiance 
versus total pulse number with low coefficient of determination values indicating no relationship 
between pulse number and pDNA delivery within the stop impedance and field strengths 
evaluated. 
Observation of animals immediately, 24 hours, and 48 hours after GET protocol showed 
no observable tissue damage in any DEI or DEIF groups.  All DEIF groups exhibited excellent 
safety profiles, there was no evidence of necrosis or scabbing similar to what occurred in DEI fixed 
pulsing groups that received 72, 250 V/cm pulses.  There was an inherent element of safety in all 
feedback groups.  Animals that received a high number of pulses necessary to achieve targeted 
stop impedances were exposed to relatively lower field strength pulses (e.g. 100 V/cm) and 
animals exposed to relatively higher field strength pulses (200 V/cm) received a lower number of 
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pulses.  The aim of GET was to reversibly permeabilize cells and not trigger apoptosis or 
irreversibly permeabilize cells (necrosis).  Gene transfer and protein production only occur in 
viable cells.  Seeing statistically higher gene delivery in animals in the DEIF groups targeting 80% 
and 95% reduction in impedance, agrees with exhibited safety profiles in these groups; more cells 
were reversibly versus irreversibly permeabilized therefore more DNA was delivered to a greater 
population of viable cells which lead to greater reporter gene expression.  Moreover, this indicates 
the impedance reductions evaluated were effective at reversibly permeabilizing cell membranes to 
a degree that facilitated gene delivery without reducing cell viability.  However, reductions in 
impedance greater than 95% near 100% may reduce expression levels because of lowered viability.  
It is likely that once the relative impedance drop exceeds a certain percent, a majority of cells will 
be irreversibly permeabilized negatively affecting DNA delivery.  Greater stop impedances must 
be evaluated to determine this. 
A primary reason for integrating feedback control into GET was to develop a method that 
could generate homogeneous permeability across all treatment sectors to control and enhance gene 
delivery.  The ability to control cell membrane permeability ensures the conditions necessary for 
targeted of gene delivery could be created.  Open loop methods lack the means necessary to ensure 
the same amount of permeability is created in all treatment sectors.  As a result, delivery of DNA 
cannot be ensured.  Additionally, fixed pulsing protocols do not compensate for differences in 
tissue architecture and therefore have no way of quantifying the degree of membrane permeability 
in tissue.  This results in sub optimal permeability and the inability to discern whether gene 
delivery was successful.  Closed loop GET methods that incorporate impedance based feedback 
provide a way to compensate for the variability in delivery associated with tissue anisotropy and 
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determine whether the conditions for facilitating DNA delivery have been created by electric 
pulses in tissue.  
  
 
  
Figure 15:  Mean peak radiance vs total pulse number for each DEIF group.  (A) 100 V/cm, 80% 
(B) 100 V/cm, 95% (C) 150 V/cm, 80% (D) 150 V/cm, 95% (E) 200 V/cm, 80% (F) 200 V/cm, 
95%.  Orange markers represent DEI groups of same field strength. 
 
The utility of the impedance-based feedback and the MEA to generate near homogeneous 
tissue permeability in a treatment region is shown in Figure 16.  The box plots in Figure 16 show 
the variability in percent impedance reduction in treatment sectors in all groups as a function of 
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field strength and stop impedance.  Significant differences in the percent reduction of impedance 
were present between sectors that were treated with an open loop GET protocol using a fixed 
number of 72 pulses.  This variability was markedly reduced when impedance based feedback 
control was used to drive pulse number.  Reduced variability in feedback groups validated the 
ability of this method to control and target permeability across all sectors which lead to enhanced 
gene delivery.  All feedback groups showed statistically greater mean radiance compared to non-
feedback groups of the same field strength.  Furthermore, the 200 V/cm feedback groups had the 
lowest variability in impedance drop per sector and exhibited the greatest mean transgene 
expression.  Figure 16 shows that variability in impedance drop decreased as field strength 
increased in DEI and DEIF groups.  In theory, higher field strengths fully charge the membrane 
faster therefore, even without feedback it was expected that higher field strength groups would 
show less variability and overall greater impedance drops in all sectors.  This data also shows 
variability in impedance drop decreased as stop impedance increased in DEIF groups.  Variability 
was lower in these groups because the minimum allowable range impedance drop was reduced.  
The 80% impedance drop groups allowed a 20% range in impedance reduction whereas the 95% 
stop impedance groups allowed 5% range in impedance reduction.  Electrode effects associated 
with indirect pulsing and electrode reuse were also consistent through DEIF groups but were 
minimized in groups receiving higher field strength pulses and higher stop impedances, again a 
result of smaller allowable range in impedance reduction.  Electrode effects were apparent in 
impedance drop patterns within columns of the electrode array that agreed with pulse number 
trends.  Sectors 1, 4, and 7 at the top of the left, central, and right columns always exhibited the 
smallest drop in impedance relative to same column sectors.  These sectors were most resistant to 
reductions in impedance associated with electrode reuse and indirect pulses and required a greater 
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number of pulses.  Because pulse sequence advanced away from these sectors the immediate 
indirect pulses, prior to sectors 4 and 7 occurred at a greater distance two sectors away in sectors 
3 and 6.  The effect of this indirect pulse on sectors 4 and 7 was therefore minimal.  The central 
sectors 2, 5, and 8 within these columns exhibited the greatest reduction in impedance while 
bottom sectors 3, 6, and 9 exhibited intermediate reductions in impedance within these columns.  
Before pulsing advanced to a central or bottom row sector the two lower left and right electrodes 
in the sector above were pulsed, as a result the top half of the adjacent downstream sector was also 
pulsed.  For example, the upper two electrodes (2 and 6) in sector 2 were used during pulsing in 
sector 1 before direct pulsing in sector 2 began.  These indirect pulses initiated reductions in 
impedance in the sectors below it.  This occurred in sectors 2 and 3 in the left column, sectors 5 
and 6 in the center column, and sectors 8 and 9 in the right column, and accounted for their larger 
drops in impedance.  This was most apparent in 100 V/cm and 150 V/cm DEI groups where the 
percent reduction in impedance was more variable and overall lower especially in sectors 1, 4, and 
7 relative to other sectors.  Many sectors in these groups did not attain target impedance drop due 
to protocol restraints in the pulse number maximum.  Some of these sectors required more than 
the maximum allowable twenty pulses and therefore either did not achieve targeted stop impedance 
or were very near it.  Sector 5 still showed the greatest impedance reduction of all sectors in all 
groups.  Most important, Figure 16 validates that tissue permeability can be controlled when pulse 
number is guided by changes in impedance.  The variability in tissue impedance was greatly 
reduced when feedback methods were integrated into GET.  Interestingly, the right column of 
sectors (S7, S8, and S9) generally showed lower reductions in impedance relative to other columns 
in DEI groups.  The 200 V/cm DEI group exhibited the least variable and greatest percent reduction 
in impedance across sectors of any group, a result of the 72 pulses each animal received which 
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was roughly 40% fewer pulses than the 200 V/cm 95% DEIF group.  In this non-feedback group, 
all downstream sectors 2, 3, 5, 6, 8, and 9 had minimal variability in impedance reduction that 
were near all 99%.  Upstream sectors 1, 4, and 7 showed smaller reductions in impedance with 
slightly greater variability relative to other sectors.  The significantly lower expression levels, 
relative lack of variability in all sectors, and the near maximum (99%) decrease in impedance in 
the 200 V/cm non-feedback group, indicated these animals were overpulsed.  It was likely that 
overpulsed tissues had a large percentage of cells that were irreversibly permeabilized which left 
a reduced number of viable transfected cells to express the reporter gene.  Although necrosis and 
visible tissue damage was not present in this group, these conditions were considered excessive 
especially when comparing expression levels of other feedback groups to the lower expression 
levels in this group.  This indicates a fine line exists between the optimum impedance reduction 
and membrane permeability needed for maximum DNA delivery versus the impedance reduction 
present in overpulsed tissue. 
Figure 16 shows the variability of the mean percent change in impedance was markedly 
reduced in all treatment sectors in DEIF groups relative to DEI groups.  The impedance drops in 
these groups were forced to the minimum stop impedance set point in most animals.  Some of the 
sectors in lower field strength groups that required the maximum number of 20 pulses did not 
achieve target impedance drops.  Electrode effects associated with electrode reuse and indirect 
pulses were still evident as mentioned previously.  Sectors 1, 4, and 7, like the DEI groups, still 
exhibited the smallest drop in impedance relative to same column sectors.  Again, this was due to 
minimal reductions in impedance associated with electrode reuse and indirect pulses.  The 
impedance drop in bottom sectors 3, 6, and 9 was slightly lower in magnitude compared to the 
respective sectors 2, 5, and 8 above them.  This was consistent in all DEIF groups.  Variability in 
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percent impedance drop was lower in all sectors as target stop impedance and field strength 
increased.  The 200 V/cm DEIF group targeting a 95% reduction in impedance, exhibited the least 
variability in impedance change between sectors.  The reduced variability in impedance reduction 
shown in DEIF animals verifies that the device and protocol used were capable of controlling and 
targeting minimum impedance drops in tissue to produce roughly similar membrane permeability 
in cells across all sectors.  The greatest amount of gene delivery was achieved in the 200 V/cm 
(highest field strength) feedback group targeting the greatest reduction in sector impedance (95%).  
This was followed by the 200 V/cm group targeting 80% impedance reduction.  The data shows 
that integrating feedback control into GET allowed for targeted reductions in tissue impedance to 
be achieved, which compensated for differences in tissue architecture.  Considering lower field 
(100 V/cm and 150 V/cm) feedback groups also produced radiances that were statistically greater 
than the 200 V/cm non-feedback group, it is likely that the near 100% impedance drops present in 
the 200 V/cm DEI group lead to sub optimal DNA uptake as a result of overpulsing in some sectors 
and underpulsing in others.  Because the 200 V/cm DEI group impedance reduction was near 100% 
in each sector it is likely that the optimum impedance reduction for DNA delivery lies within a 
small range greater than or equal to 95% and less than or equal to 99%.  The differences in radiance 
of different field strength groups targeting the same stop impedance, as supported by Figure 14, 
implies there was as an element of quality to the permeability that may be a function of the number 
and size of permeabilized regions in the cell membrane.  The highest field strength created the 
quality of permeability optimum for DNA delivery.  Two hundred V/cm electric pulses targeting 
a 95% reduction in impedance produced the greatest mean pDNA delivery with the least variable 
impedance drops.  Therefore, these parameters generated the quality and magnitude of membrane 
permeability best suited for DNA delivery.  It is important to note that the reported impedance 
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drop in each sector was measured when the pulsing sequence had advanced to that sector.  This 
does not indicate the final impedance reduction generated in sectors only the minimum reduction 
in impedance.  Additional reductions in impedance in upstream sectors caused by indirect pulses 
and electrode reuse in downstream sectors already having achieved target stop impedance were 
present but not measured. 
 
Figure 16:  Mean percent impedance change box plots versus sectors 1, 2, 3, 4, 5, 6, 7, 8, and 9 
for all DEI and DEIF groups. 
The major difference between DEIF groups and the DEI groups of the same field strength 
was not only the total number of pulses but in the distribution of pulses over sectors.  All animals 
in DEI groups received 72 pulses as compared to the 21 and 51 respective mean total number of 
pulses required in the 80% and 95%, 200 V/cm feedback groups.  Table 8 shows that in sectors 
where electrode reuse was higher fewer pulses were required.  For example, sectors 2, 5, 6, and 8 
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required a mean number of 3, 2, 3, and 2, pulses respectively to achieve a 95% reduction in 
impedance.  Peripheral sectors 1, 4, and 7, where electrode reuse and indirect pulsing effects were 
lower, required a mean of 14, 8, and 10 pulses to achieve a 95% stop impedance.  Only 4.2% (27 
out of all 648 sectors in feedback animals) required the 8 pulses DEI groups received which has 
been an accepted optimum number of pulses used in many open protocol approaches.  This 
underscores the need to provide the dose of electric field exposure commensurate with tissue 
architecture that also compensates for electrode geometry to generate a non-lethal degree of 
permeability that is optimum for DNA uptake.  There is no single number of pulses considered 
optimum.  The results from these feedback groups and the reduced number of pulses they required 
indicate the reduced expression in the DEI group was more than likely caused by overpulsing.  
More importantly, closed loop pulsing that was based on targeted impedance drops eliminated 
overpulsing.  In DEI groups, fixed pulse number and electrode effects resulted in suboptimal 
responses to electric fields and variable permeabilities across sectors; however, the impedance 
guided pulse number in DEIF groups was able to account for these effects as well as tissue 
anisotropy and ensure a targeted permeability was achieved across sectors.  The feedback 
controlled pulsing ensured targeted permeability was achieved in all sectors, maximizing the 
population of cells primed for DNA uptake and significantly increased gene expression in all 
feedback groups. 
5.3.3 Impedance Spectroscopy 
Assuming that tissue is roughly comprised of components with resistive (intra/extracellular 
fluid and transmembrane pores) and capacitive (lipid membrane) nature some qualitative 
implications can be made with respect to what is happening physiologically during GET if these 
biologic structures are treated as electric components.  Passive membrane capacitance has been 
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proposed to have frequency dependent relaxation mechanisms within the 1 kHz to 100 MHz range 
referred to as β dispersions [95].  Therefore, impedance measurements over this range of 
frequencies can provide quantitative information about tissue components that have these 
relaxation mechanisms.  A simplified circuit model was used to describe the electrical 
characteristics of the epidermis comprised of a resistance in series with a resistor in parallel with 
a capacitor, referred to as Randle’s circuit (Figure 17).  However to account for any non-ideal 
charge storage behavior a constant phase element was substituted for the capacitor.  Where Rs 
represents the resistance exterior to cells comprised of the extracellular fluid matrix and the stratum 
corneum.  Rm represents the resistance of permeabilized regions of plasma membranes and the Cdl 
characterizes the charge storage behavior of plasma membranes.  Generally, at higher frequencies 
within the dispersion zone, capacitive reactance contributes more to the magnitude of impedance 
as current is shunted to charge the membrane.  This pathway is the least resistive due to the 
increased rate of current oscillations and the reduced amount of charge stored on membranes.  
Conversely, at lower frequencies, resistive components contribute most to the magnitude of 
impedance where the capacitor (cell membranes) acts as an open circuit and current is shunted 
through leaks and permeabilized regions of membranes.  Therefore, high frequency impedance 
norms describe the cumulative capacity of cell membranes within in the treated volume to store 
charge and low frequency impedance norms describe the movement of current through leaks and 
permeabilized regions of cell membranes.  The skin, including the layers of the epidermis, dermis, 
hypodermis, and deep layers of muscle were all assumed to have no inductive components.  This 
agreed with the semicircular shape of impedance spectra exhibited by all animals in all groups.  
This incomplete semicircle was a result of the range of frequencies used to collect impedance data.  
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Nyquist plots were used to assess the relative magnitudes of these different mechanisms to better 
understand what occurred at the cellular level during GET. 
 
Figure 17:  Epidermis circuit model. 
 
 
Figure 18:  100 V/cm DEI group, single animal Nyquist plots for each sector before (orange) and 
after (blue) pulsing. 
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A change in the permeability of tissue due to EF pulses was confirmed by differences in 
before and after electric field pulsing Nyquist curves in all groups.  As field strength and stop 
impedance increased, these differences became larger and more obvious.  Figure 18 shows Nyquist 
plots for all sectors in a representative animal before and after EF pulses in the 100 V/cm DEI 
group where each sector received a fixed number of 8 pulses for a total of 72 pulses over the 
duration of the protocol.  Differences in before Nyquist curves between sectors was a function of 
variations in tissue properties and measurement noise, again supporting the need for feedback 
control to account for the unique tissue architecture of each treatment region.  The after Nyquist 
curves show a marked decrease in the magnitude and shape of impedance loci relative to skin that 
had not yet received EF pulses.  In Figure 18, before pulsing (orange) Nyquist plots were 
semicircular in shape confirming the RC nature of cells in tissue that was also in series with an 
additional resistance represented by the positive horizontal shift of the Nyquist trace.  The 
horizontal shift present in all before and after Nyquist plots likely represented the resistance of the 
stratum corneum and extracellular fluid residing in the interstitial compartments around cells.  
However, the magnitude of the extracellular compartment resistance was considered negligible 
relative to the stratum corneum resistance.  The same semicircular shape indicative of parallel RC 
nature was present in the after EF pulse Nyquist plots (blue) however, major reductions in 
resistance and reactance were present resulting in a flattened and horizontally compressed Nyquist 
signature.  The reduction in resistive and reactive components validated that the opposition to 
current flow through tissue was decreased after pulsing and that new current pathways were 
present.  Because the short 150 ms duration of GET pulses were not expected to contribute to any 
significant change in the conductivity of the interstitial compartments prior to a permeabilization 
event, these new current pathways were expected to exist through cell membranes because of the 
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permeability induced by electric fields.  Additionally, all after pulsing Nyquist plots in all 
treatment groups exhibited positive horizontal shifts relative to before pulsing Nyquist plots.  This 
shift implied an increase in the stratum corneum resistance was present after pulsing.  Current flow 
through tissue during GET pulses increased the temperature of the semi-solid phase stratum 
corneum causing an increase in its resistance.  This agreed with the increase in temperature of 
tissue sensed by fingertips that supported the MEA during execution of the GET protocol.  A 
change in the shape of Nyquist traces represented a change in the charge storage capability of 
membranes and the charge transfer through them.  The increased permeability of cell membranes 
induced by pulsed electric fields indicated the conditions proposed for the GET mechanism were 
initiated.  This was supported by the significantly enhanced radiance of all treatment groups 
relative to the DO group.  Electrode effects were pronounced in non-feedback groups relative to 
feedback groups especially at higher field strengths where they were marked.  Evidence of 
electrode reuse, indirect pulsing, and pulse sequence effects were present in differences in after 
Nyquist plots usually between the lower right quadrant of the array (sectors 5, 6, 8, and 9) and the 
remaining sectors especially sectors 1, 4, and 7.  In sectors 5, 6, 8, and 9, the reduction in both 
resistance and reactance was significantly greater as can be seen by the flattened and compressed 
after pulsing Nyquist curves.  Relatively shorter and flatter after Nyquist curves identify treatment 
regions where tissue was permeabilized more by EF pulses.  Figure 18 shows this in the 100 V/cm 
DEI group after Nyquist curves of sectors 2, 5, 6, and 8 which had lower resistance and reactance 
values across all frequencies compared to other sectors.  Figure 16 also confirms this, supporting 
these sectors as consistently having the greater mean impedance reduction compared to other 
sectors.  Sector 7 consistently appeared to have the lowest reduction in impedance and was 
expected to have the lowest degree of permeability and gene delivery.  Considering all treatment 
85 
sectors in this group received the same number of pulses, the consistent pattern in the differences 
between after Nyquist plots for the bottom right quadrant of sectors and the top row and left column 
of sectors indicated an unequal exposure of treatment regions to electric fields.  The permeabilizing 
effects induced by electric fields were not balanced equally across all sectors due to electrode reuse 
and pulse sequence effects, and to a much lesser extent tissue architecture.  The lower radiance in 
this group confirms this and indicates the limitations of open loop GET methods.  The concomitant 
flattening and reduction in real and imaginary components of impedance do indicate a significantly 
decreased time constant in all sectors.  A decrease in the RC time constant indicated the time 
required to charge the capacitive membrane was decreased because of a reduction in membrane 
integrity. 
 
Figure 19:  100 V/cm, 95% DEIF group, single animal Nyquist plots for each sector before 
(orange) and after pulsing. 
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Nyquist plots from the 100 V/cm field DEIF group targeting a 95% stop impedance shown 
in Figure 19, provide evidence of a more homogenous reduction in impedance across all sectors 
when minimum impedance reductions were targeted with a closed loop protocol.  The 100 V/cm 
DEIF group targeting 80% stop impedance exhibited similar Nyquist plots (not shown) however 
magnitudes of impedance loci were slightly greater as expected due to the lower stop impedance 
that was targeted.  The after Nyquist traces in Figure 19 show a greater reduction in impedance 
loci at all frequencies in all sectors compared to the non-feedback group of the same field strength 
shown in Figure 18.  This indicated permeability in the 95% DEIF group was greater than the DEI 
group of the same field strength.  Differences in post EF pulsing impedance Nyquist plots between 
sectors associated with electrode effects and tissue anisotropy were reduced relative to the DEI 
group but still present.  Sectors in the left column and top row of the array still exhibited smaller 
reductions in impedance loci at all frequencies when compared to the lower right quadrant of 
sectors.  The shape and magnitude of impedance spectra for these peripheral sectors remained 
semicircular whereas the impedance spectra for the lower right quadrant of sectors appeared to be 
roughly linear and almost horizontal.  This implies the degree and quality of permeability was 
different between these groups of sectors.  The reduced values of resistance and reactance in the 
lower right quadrant of sectors at all frequencies does imply that permeability was greatest in these 
sectors therefore it is expected delivery was also greater in these sectors.  Furthermore, the linear 
impedance spectra exhibit a very low, near horizontal slope indicating reactance or capacitance 
changed very little in magnitude with frequency.  In other words, the reactance and capacitance 
were roughly constant due to membrane permeability reaching a near maximum.  A linear 
impedance spectrum with a slope approaching zero over a small range of resistances may be the 
strongest evidence of high permeability and DNA uptake.  Using feedback to target a specific 
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impedance drop reduced electrode effects and accounted for differences in tissue architecture 
ensuring a greater minimum permeability was achieved in more sectors.  This feedback approach 
ensured tissue in all sectors was permeabilized to a greater degree, which significantly enhanced 
transfection.  Targeting a minimum impedance reduction of at least 80% and 95% with 100 V/cm 
electric pulses resulted in respective 3.0 and 2.4 fold increases in radiance over the non-feedback 
group of the same field strength. 
 
Figure 20:  150 V/cm DEI group, single animal Nyquist plots for each sector before (orange) and 
after (blue) pulsing. 
 
Figure 20 shows the before (orange) and after (blue) pulsing Nyquist plots for all sectors 
for a representative animal from the 150 V/cm DEI group.  All sectors exhibited significant 
reductions in impedance loci at all frequencies, however the reduction in after pulsing (blue) 
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Nyquist plots in the lower right quadrant of sectors was markedly greater than other sectors.  The 
shape of impedance spectra between these groups of sectors was also very different implying the 
degree and quality of permeability was also different.  Considering all treatment sectors in this 
group received the same number of pulses, the marked differences between the permeability 
present in these two groups of sectors indicated an unequal exposure of treatment regions to field 
conditions which was even greater than what was seen in the 100 V/cm DEI group.  The 
permeabilizing effects induced by electric fields were not balanced equally across all sectors due 
to electrode geometry and tissue anisotropy.  This was further exacerbated by greater field 
strengths.  The lower mean radiance of this group supports this and indicated the limitations to 
delivery that are present in open loop GET methods where targeted minimum permeability across 
sectors cannot be ensured.  The after electric field pulsing impedance loci were reduced in all 
sectors and but only semicircular in shape for sectors in the upper row and left column in the array 
(S1, S2, S3, S4, and S7).  The retained semicircular shape in these peripheral sectors indicated the 
phase angle of the impedance in tissue in these sectors was still dependent on frequency more than 
likely because membrane integrity remained relatively intact compared to the lower right quadrant 
of sectors.  The after Nyquist plots for the lower right hand quadrant of sectors 5, 6, 8, and 9 were 
significantly different in shape with large reductions in resistance and reactance values indicating 
the degree of permeability was greater in these sectors.  Reactance in these sectors varied over a 
small range compared to resistance because the membrane capacitance became stable.  These 
sectors exhibited roughly linear impedance spectra showing that reactance in these sectors did not 
change appreciable with frequency.  Measurement noise was also reduced in these sectors; a 
possible result of preferential current pathways that were established after changes in permeability 
became less variable with each pulse.  As permeability in these sectors became stable so too did 
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current pathways resulting in a reduction in measurement variability.  The lower expression of this 
non-feedback group relative to the 150 V/cm feedback groups indicated this combination of 
impedance spectra did not reflect the degree or quality of permeability that were optimum for DNA 
uptake.  The presence of two different types of permeability in this group make it difficult to assess 
which impedance spectra correlated with optimum DNA uptake. 
 
Figure 21:  150 V/cm, 95% DEIF group, single animal Nyquist plots for each sector before 
(orange) and after pulsing. 
 
Figure 21 shows the before and after Nyquist plots for all sectors in a representative animal 
from the 150 V/cm DEIF group targeting a 95% impedance reduction.  Like the 100 V/cm, 95% 
DEIF group this group also showed more homogeneous impedance reductions across all sectors 
however, impedance loci were reduced a greater extent in more sectors.  The 150 V/cm DEIF 
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group targeting 80% stop impedance exhibited similar Nyquist plots (not shown) with respect to 
shape and homogeneity of impedance changes however magnitudes of impedance loci were 
slightly greater due to the lower targeted stop impedance.  The after Nyquist traces in Figure 21 
show a greater reduction in impedance loci at all frequencies in all sectors compared to the non-
feedback group of the same field strength (Figure 20) which indicated the permeability in the 95% 
DEIF group after pulsing was greater than the DEI group of the same field strength.  Differences 
in after EF pulsing impedance spectra between sectors associated with electrode effects and tissue 
anisotropy were minimized but still present.  Peripheral sectors 2, 3, 4, and 7 (top row and left 
column of sectors) exhibited impedance spectra that were the same shape as those of the lower 
right quadrant of sectors.  This was evidence that the closed loop method was able to compensate 
for electrode reuse and tissue architecture.  More importantly, this indicated that using a closed 
loop protocol to target a minimum reduction in impedance of 95% in all sectors with 150 V/cm 
electric pulses generated a consistent degree of permeability in 8 out of 9 sectors.  This was a 
significant improvement over the 100 V/cm 95% stop impedance group that showed only 4 out of 
9 sectors had marked increases in tissue permeability.  The greater reduction in impedance loci in 
8 of 9 sectors compared to the 150 V/cm non-feedback group was expected to have contributed to 
the greater DNA delivery seen in in this group.  Sector 1 was the only sector with a semicircular 
after pulsing impedance spectra.  Sectors 2 through 9 all had roughly linear spectra with slopes 
near zero indicating reactance and capacitance of tissues in these sectors changed very little with 
frequency.  It was expected that the reactance and cumulative membrane capacitance in these 8 
sectors was more than likely near its lowest and stable achievable value respectively.  The quality 
and degree of permeability in sectors 2 through 9 was near the optimum for DNA uptake 
accounting for the 2.3 fold increase in pDNA delivery seen by this group relative to the non-
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feedback group of the same field (150 V/cm).  The indicative of the impedance spectra that 
correlate with enhanced DNA uptake. 
Figure 22 shows before (orange) and after (blue) electric field pulsing impedance spectra 
from a representative animal in the 200 V/cm DEI group.  Significant differences in the 
permeability present after pulsing between the top row of sectors and remaining sectors indicate 
the impact electrode effects and tissue architecture had on delivery.  The open loop method used 
in this group did not compensate for these effects and as a result the permeability between sectors 
was not homogeneous.  These effects were concentrated in all downstream sectors in the central 
and bottom rows of the array.  The top row of sectors exhibited significantly smaller reductions in 
impedance loci relative to lower sectors.  Impedance spectra in sectors 2, 3, 5, 6, 8, and 9 exhibited 
reactance values that were near zero and roughly constant relative to the range and magnitude of 
resistance values.  The after Nyquist plots for these sectors may be indicative of over pulsed tissue 
considering the low mean radiance exhibited by this group.  Sector 5 impedance spectrum shows 
resistance and reactance were almost constant as frequency changed relative to the before pulsing 
spectrum.  Permeability in this sector and in sectors with similar impedance spectra may have been 
near maximum and signified irreversible permeability in a large portion of cells.  This was a result 
of over pulsing in the bottom two rows of sectors.  The remaining population that had not been 
irreversibly permeabilized contributed to the reduced radiance seen in Figure 12.  Even though this 
group showed statistically higher radiance relative to the DO group, these impedance spectra 
represent suboptimal permeability when compared to the 80% and 95% feedback groups of the 
same field that exhibited 5.8 and 6.8 fold increases in radiance relative to this group respectively.  
Interestingly, the sectors exhibiting these large reductions in resistance and impedance also had an 
equally noticeable reduction in measurement variability or noise.  This may be another dimension 
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of impedance spectra indicative of the quality of the permeability created by pulses.  The 
statistically lower expression of this non-feedback group relative to the 200 V/cm feedback groups 
indicate this combination of impedance spectra did not reflect the degree or quality of permeability 
optimum for DNA uptake. 
 
Figure 22:  200 V/cm DEI group, single animal Nyquist plots for each sector before (orange) 
and after (blue) pulsing. 
 Figure 23 shows before (orange) and after electric field pulsing impedance spectra from a 
representative animal in the 200 V/cm, 95% stop impedance DEIF group.  Like the other DEIF 
groups, this group also showed more homogeneous impedance reductions across all sectors.  
Impedance spectra for the 200 V/cm 80% DEIF group (not shown) exhibited slightly greater 
resistance and reactance values at lower frequencies and generally more sectors retained after 
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pulsing impedance spectra with semicircular shape.  The 200 V/cm, 95% DEIF group generally 
exhibited more sectors with linear or near horizontal impedance spectra.  Electrode reuse, indirect 
pulsing, and pulse sequence effects were less prevalent as shown by the very similar impedance 
spectra in 8 of 9 sectors.  The peripheral sectors 2, 3, 4, and 7 (top row and left column of sectors) 
exhibited impedance spectra that were near the same shape and magnitude as those of the lower 
right quadrant of sectors, evidence that electrode reuse and sequence effects were minimal but not 
absent.  The impedance spectra of these peripheral sectors showed greater resistance values at low 
frequencies relative to other sectors indicating permeability of membranes in these regions of 
tissue was also relatively lower.  Figure 23 shows sector one was the only sector with a relatively 
semicircular after pulsing impedance spectra.  Sectors 2 through 9 all had roughly linear spectra 
with slopes approaching zero indicating reactance of tissue in these sectors changed very little with 
frequency and was more than likely near its lowest achievable value before a significant portion 
of cells were irreversibly permeabilized.  At this point, the available area of membranes to store 
charge was near constant.  The quality and degree of permeability in sectors 2 through 9 was near 
the optimum for DNA uptake accounting for the statistically greater 6.8 fold increase in DNA 
delivery seen by this group relative to the non-feedback group of the same field (200 V/cm).  Given 
the high radiance and the general similarity of impedance spectra in all sectors in this group, it is 
likely that spectra with this shape and magnitude may be indicative of the degree and quality of 
impedance that correlates best with enhanced DNA uptake.   
At first glance, comparison of impedance spectra from the 200 V/cm DEI and 200 V/cm, 
95% DEIF groups revealed almost no discernable difference between impedance loci in 
corresponding sectors.  However, closer analysis of these spectra revealed subtle differences were 
present.  The difference in resistance values from the lowest and highest frequency data points in 
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the impedance spectra provide a qualitative measure of the cumulative resistance in tissue 
associated with charge transfer through membranes.  If a larger range of frequencies had been used 
to capture the complete dispersion mechanism under investigation, the resulting impedance spectra 
would more than likely have had two loci where reactance values were zero.  The difference in the 
real coordinates (resistance) between these points on the complex plane quantifies the cumulative 
resistance of charge transfer through cell membranes or Rm from Figure 17 in tissue - a direct 
measurement of membrane permeability.  However, because these points were not attained within 
the frequencies that were used, this value can be estimated by comparing the magnitude of the 
difference in resistance between the real coordinates of the impedance loci for the highest and 
lowest frequency impedance loci of each spectra.  This value qualitatively describes the degree of 
horizontal compression of impedance spectra.  It can be used to compare the transmembrane 
charge transfer resistance (Rm) in corresponding sectors between groups.  Given that the horizontal 
compression of the impedance spectra was greater in corresponding sectors of the 200 V/cm DEI 
group relative to the 200 V/cm DEIF group targeting 95% impedance reduction, it was expected 
that Rm was lower in 200 V/cm DEI group sectors which.  This represented a degree of membrane 
permeable that was less resistive or permeable to current flow.  For example, the Rm represented 
by the compression of impedance spectra similar to that in sector 5 of Figure 22 may be too great 
and represent a very low Rm indicative of irreversible permeability.  Overall, the cumulative 
transmembrane charge transfer resistance in sectors of the 200 V/cm DEIF, 95% group in Figure 
23 was greater relative to spectra in corresponding sectors of the 200 V/cm DEIF group.  However, 
without spatial resolution in radiance data, it was difficult to determine which spectra and Rm was 
optimum for transfection.  This also underscored the fine line that exists between irreversible 
permeability and permeability that is optimum for DNA uptake.  Moreover, these differences were 
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only exploitable when impedance based feedback was used to guide the number of applied electric 
pulses which, in the process, validated the utility of this method. 
 
Figure 23:  200 V/cm, 95% DEIF group, single animal Nyquist plots for each sector before 
(orange) and after pulsing. 
 
 To help define the upper limits of permeability it was necessary to evaluate spectra from a 
group with conditions that induced tissue damage where irreversible permeability had been 
created.  Figure 24 represents after pulsing Nyquist plots in a representative from the 250 V/cm 
DEI (non-feedback) group that received 8 EF pulses per sector animal and showed tissue damage 
at the treatment site with significantly low expression levels.  This field strength was considered 
to irreversibly permeabilize tissues when used in non-feedback protocols where 72 pulses were 
administered.  Irreversibly permeabilized sectors exhibited linear after pulsing Nyquist plots with 
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reactance magnitudes that were near zero at all frequencies.  The permeability in animals of this 
group was near maximum because a large portion of cells had been irreversibly permeabilized.  
The magnitude and shape of these impedance spectra were indicative of the degree and quality of 
impedance that correlated best with irreversible permeability and should be avoided. 
 
Figure 24:  Before pulsing (orange) and after pulsing (blue) Nyquist plots for a representative 
animal from the 250 V/cm DEI group, 8 pulses per sector. 
 
5.4 Conclusion 
The motivation of this work was to investigate the utility of a closed loop GET method to 
control tissue permeability during electric field exposure for delivering gene constructs to cells in 
vivo.  This is not practiced by the current state of the art.  It was expected that targeting relative 
changes in tissue permeability with pre and interpulse impedance measurements, had the potential 
to ensure the conditions necessary for maximum gene delivery were created.  This could enhance 
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the biological response and reliability of this method.  This study showed that 200 V/cm pulsed 
electric fields targeting a 95% reduction in tissue impedance produced mean transgene expression 
levels that were 6.8 fold greater than open loop methods and 13.7 fold greater than non-electric 
field mediated pDNA injection only.  Furthermore, the quality of permeability induced by electric 
fields was evidently dependent on the field strength and critical for increasing delivery.  Feedback 
groups targeting the same reduction in tissue impedance with different field strengths showed that 
permeability induced by the highest electric field strength (200 V/cm) delivered more pDNA than 
other lower field strength groups.  The impedance spectra and relatively attenuated expression 
exhibited by open loop protocol groups revealed the hindering effects of the multielectrode array, 
anisotropic tissue architecture, and fixed pulsing on gene delivery.  When impedance-based 
feedback was used to guide pulse number to target a reduction in impedance, these effects were 
significantly minimized and almost abolished.  As a result, in feedback groups, treatment sectors 
were subjected to the unique amount of electric field exposure necessary to account for differences 
in tissue architecture and electrode/protocol associated effects.  This generated homogenous 
degrees of permeability across all sectors of treated tissue, not present in open loop methods, which 
contributed to significant increases in gene delivery.  Not only did this feedback based GET 
method enhance delivery, but it also proved this approach may be universally applied to a near 
infinite number of electrode geometries because of its ability to account for tissue architecture and 
effects associated with multielectrode designs.  These two discoveries should make significant 
contributions to the field and help advance GET methods to an even more widely accepted space 
in clinical medicine where it can be used to improve the quality of life of many. 
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CHAPTER 6:  DISCUSSION AND FUTURE DIRECTIONS 
 
6.1 Discussion 
Electric field mediated gene delivery has gained popularity as a result of its ability to 
deliver nucleic acid constructs rapidly and with relatively high transfection efficiencies.  The non-
viral nature of these electric field based methods has engendered great interest as they have highly 
preferable safety profiles when compared to viral based delivery.  However, the current state of 
the art utilizes empirically derived parameters that do not monitor cell/tissue responses to electric 
pulses, indicate if delivery was successful, target degree of permeability, or optimize electric pulse 
parameters in real time.  This open loop approach does not account for anisotropic tissue 
architecture or compensate for electrode design/protocol effects that result in variable and sub 
therapeutic delivery efficiencies.  This work showed that to ensure targeted transfection 
efficiencies can be achieved consistently closed loop methods need to be developed that optimize 
pulsing parameters in real time to apply the unique dose of electric field stimulation needed to 
achieve a desired level of membrane permeability.  The electrical nature of GET and required 
hardware conveniently positions this method to incorporate other electric based controls that can 
be used to ensure gene delivery occurs.  Impedance spectroscopy provided a way to quantify the 
transient permeability created in cell membranes after electric field exposure making it ideal for 
use as feedback control variable. 
The device constructed for these experiments integrated a custom software controlled, dual 
mode capability high voltage/low voltage pulsing system, tethered to a multielectrode array 
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applicator.  The 32 solid-state relays with 50 ms switching times allowed low voltage impedance 
chirps to measure impedance almost instantaneously after high voltage GET pulses.  Custom 
software utilized a Fast Fourier Transform (FFT) to transform time dependent voltage and current 
waveforms into the frequency domain for calculating baseline and post pulse tissue impedance. 
Treatment groups were formed to evaluate impedance-based feedback to optimize pulse 
number for achieving either 80% or 95% impedance drops in each treatment sector.  The 
magnitude of impedance reduction was expected to indicate the degree of permeability in cell 
membranes, ensure roughly homogenous delivery across sectors, and significantly enhance gene 
delivery.  Experiments conducted in animals showed reporter gene expression increased with field 
strength up to 200 V/cm and with target stop impedance.  The 200 V/cm feedback groups targeting 
95% and 80% impedance drops showed 14 and 11 fold increases in radiance relative to injection 
alone respectively, and 7 and 5 fold increases in radiance relative to the non-feedback group of the 
same field strength respectively.  These results confirmed the use of impedance based feedback 
control to enhance gene delivery. 
It was expected that impedance might indicate changes in the available current pathways 
or permeability present in tissue associated with electric pulses.  This followed the logic that as 
impedance decreased additional pathways for current through cell membranes would also increase.  
Therefore, a reduction in impedance indicated an increase in membrane permeability and the 
mechanism responsible for the uptake of genetic constructs by cells had been initiated.  Results 
supported this reasoning however, it there was a fine difference between optimum membrane 
permeability/impedance drop and irreversible permeabilization.  Although visible cell death or 
tissue damage was not visible the significantly lower radiance levels in the 200 V/cm non feedback 
group indicate the 72 pulses these animals received created overpulsed responses in some sectors 
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where irreversible membrane permeability was present and underpulsed responses in others 
sectors.  This resulted in reduced gene delivery relative to DEIF groups that was still statistically 
greater than DNA injection only groups.  In comparison, animals that received the same field 
strength (200 V/cm) and a mean total of 101 pulses where pulses were varied to target 95 % 
reductions in treatment sector impedance, exhibited a 6.8 fold increase in radiance relative to the 
200 V/cm DEI group.  This proved that impedance based feedback could guide pulse number to 
compensate for electrode and pulse sequence effects and anisotropic tissue architecture.  All DEIF 
groups exhibited a variable distribution of pulses across sectors to provide the unique amount of 
electric field exposure to each sector necessary for inducing a targeted permeability optimum for 
pDNA uptake. 
Experimental results showed that by controlling pulse number to target a desired 
impedance drop across all sectors, an optimum degree of membrane permeability could be 
achieved to enhance DNA uptake.  This validates the utility of impedance-based feedback in GET 
methods to increase gene delivery when compared to open loop methods. 
6.2 Future Directions 
Although gene delivery was improved in GET protocols employing feedback control, 
statistical power was hindered by inherent variability in biological response data and small sample 
sizes.  In order to establish statistically different delivery profiles between feedback groups 
targeting 80% and 95% exposed to the same EF pulse strength, a larger sample size is needed.  The 
method for calculating impedance drop in these experiments used the baseline mean value 
impedance magnitude from 1 kHz to 3 kHz for normalization.  This low frequency interval 
generally characterizes the resistive components of the cells and tissue.  Using relative changes in 
high frequency intervals of the impedance magnitude may provide more insight into the status of 
101 
the membrane and therefore provide for better control when targeting a desired membrane 
permeability.  This may be a better feedback variable as it may more accurately describe the 
cumulative charge storage capacity of cell membranes in tissue which may correlate better with 
delivery and the relative degree of membrane permeability present after each pulse.  
The electrode design and pulse sequence pattern used in this study did not expose sectors 
to an equal amount of electric field stimulation when a fixed pulse number was used in each sector.  
Effects associated with electrode reuse and the indirect exposure of sectors to fields in 
upstream/downstream sectors clouded the exact impedance changes associated with direct pulses 
in a sector.  Because of this, the minimum relative impedance change was known instead of the 
final relative sector impedance change.  More experiments need to be done that pulse and measure 
in only one sector while monitoring reporter gene expression to identify the true impedance 
reduction and spectra that correlates with maximum transgene expression. 
The probing depth of the electric fields generated by the 2 mm spacing used in the MEA 
requires further validation.  The impedance spectra collected were assumed to provide information 
within the region of tissue where volume of pDNA was injected.  This was never confirmed.  Other 
possible impedance measurement techniques should also be explored that incorporate passive 
sensing electrodes not responsible for injecting current into tissue. 
Future work should utilize impedance-based feedback to investigate the mechanism of 
action occurring in gene electrotransfer.  To remove the confounding effects of extracellular matrix 
components and an infinitely large set of cell/tissue architecture configurations, impedance 
spectroscopy must be adapted to single cell analysis in vitro.  This may shed much needed light 
onto a disputed mechanism and more importantly advance the state of the art to allow the potential 
of gene-based medicine to be realized.  Finally, the culmination of this litany of proposals and 
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recommendations would be the assessment of closed loop GET methods to consistently induce 
clinically relevant outcomes.  
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